syndrome	score	normalized_score
PARAMYOTONIA CONGENITA OF VON EULENBURG	4.344961900000001	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	46.030323073718996
MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	1.083334	24.93310700837215
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.0	23.015161536859498
HORNER SYNDROME, CONGENITAL	1.0	23.015161536859498
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0	23.015161536859498
ANAPLASTIC THYROID CARCINOMA	1.0	23.015161536859498
DEXTROCARDIA	1.0	23.015161536859498
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.91961685	21.165130354767893
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.7872689	18.119120906445687
RICHIERI COSTA-DA SILVA SYNDROME	0.7081121899999999	16.297316439069345
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.5526316	12.718905544373124
GNE MYOPATHY	0.5473422	12.59716914894006
AURICULOCONDYLAR SYNDROME	0.5285714	12.165156154763977
RIPPLING MUSCLE DISEASE; RMD	0.5120482	11.78487203765814
RIPPLING MUSCLE DISEASE 1; RMD1	0.5120482	11.78487203765814
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.50316456	11.580413628022832
OBESITY DUE TO SIM1 DEFICIENCY	0.5	11.507580768429749
RIGID SPINE MUSCULAR DYSTROPHY 1	0.5	11.507580768429749
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	11.507580768429749
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.5	11.507580768429749
MYOPATHY AND DIABETES MELLITUS	0.47564100000000004	10.94695444855339
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.47483770000000003	10.928466369290831
MULTIPLE SYSTEM ATROPHY	0.47483770000000003	10.928466369290831
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.47483770000000003	10.928466369290831
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.45387597	10.446028767248796
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.4523813	10.411628695754498
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.4242421	9.764000462236503
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.41233770000000003	9.490018773237113
SYRINGOMYELIA, ISOLATED	0.392857	9.041667315886013
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.3544849	8.158527235877486
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.35247812000000006	8.112340870008548
SALT-AND-PEPPER SYNDROME	0.33976266	7.819692504093072
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.33641941999999997	7.742747295436581
PIERPONT SYNDROME	0.333333	7.671712840565988
ARNOLD-CHIARI MALFORMATION TYPE I	0.3125	7.192237980268594
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.309524	7.1237448595349
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.2961107	6.815035593292543
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.28571430000000003	6.575760767890737
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.2857143	6.575760767890736
INCLUSION BODY MYOSITIS	0.27503520000000004	6.329979556322461
ZEBRA BODY MYOPATHY	0.269204	6.1957735463687245
NEMALINE MYOPATHY 7; NEM7	0.26785020000000004	6.1646156206801255
DERMATOMYOSITIS	0.2655943	6.112695717769123
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.265174	6.103022445375181
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.26321337	6.057898229211168
DISTAL MYOPATHY, TATEYAMA TYPE	0.2616279	6.021408381049324
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.2616279	6.021408381049324
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.2616279	6.021408381049324
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.25757610000000003	5.928155549534277
BARTH SYNDROME; BTHS	0.25699438	5.914767169765055
CHIARI MALFORMATION TYPE I	0.25537634	5.877527717791954
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.25414938	5.8492890351926885
INCLUSION BODY MYOSITIS	0.25308642	5.824824839085468
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.25	5.7537903842148745
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.25	5.7537903842148745
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.25	5.7537903842148745
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.2280223	5.247970068506238
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.225641	5.193164064338514
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.225641	5.193164064338514
STUVE-WIEDEMANN SYNDROME	0.22390778000000003	5.1532737260595995
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.2140092	4.925456308374073
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.212987	4.901930210251095
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.21228052	4.885670458928534
STÜVE-WIEDEMANN SYNDROME	0.20777868000000002	4.782059884115439
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.20649595	4.752537645957262
NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	0.20387597000000002	4.692238383033922
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.20238130000000001	4.657838311539623
METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASEA	0.2	4.6030323073719
MUNGAN SYNDROME	0.2	4.6030323073719
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.18561915	4.272054721584554
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.18214105	4.192005688243203
LAING EARLY-ONSET DISTAL MYOPATHY	0.18174318	4.182848645922533
AL AMYLOIDOSIS	0.18150880000000003	4.177454352361524
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.1800003	4.142735981183171
DERMATOLEUKODYSTROPHY	0.179654	4.134765830742957
MULTIMINICORE MYOPATHY	0.17871520000000002	4.113159197092154
NORRIE DISEASE	0.17288435	3.978961242444955
PGM3-CDG	0.17051315	3.9243876914087545
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.1702131	3.91748199218962
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17011528	3.915230649088084
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.16849799999999998	3.8780086886377516
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	3.8358679278637626
MUCOLIPIDOSIS TYPE II	0.166667	3.8358679278637626
CEREBROOCULONASAL SYNDROME	0.166667	3.8358679278637626
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.166667	3.8358679278637626
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.166667	3.8358679278637626
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.166667	3.8358679278637626
MIYOSHI MYOPATHY	0.166667	3.8358679278637626
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.166667	3.8358679278637626
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.166667	3.8358679278637626
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.1666665	3.835856420282994
WILD TYPE ATTR AMYLOIDOSIS	0.16233770000000003	3.736228389022237
VARIANT ABETA2M AMYLOIDOSIS	0.16233770000000003	3.736228389022237
MYOTILINOPATHY	0.16041007000000002	3.6918636731889403
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.14594342	3.358911386541731
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.14594342	3.358911386541731
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.14594342	3.358911386541731
AUTOIMMUNE HYPOPARATHYROIDISM	0.14594342	3.358911386541731
PHACE ASSOCIATION	0.14285699999999998	3.2878769316711374
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.14285699999999998	3.2878769316711374
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.14285699999999998	3.2878769316711374
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	3.2878769316711374
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.14285699999999998	3.2878769316711374
%109500 BASILAR IMPRESSION, PRIMARY	0.14285699999999998	3.2878769316711374
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.14285699999999998	3.2878769316711374
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	3.2878769316711374
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	3.2878769316711374
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.14138824	3.25407318301226
POEMS SYNDROME	0.13415807	3.087669652523304
CARIBBEAN PARKINSONISM	0.133787	3.079129416531822
SCLERODERMA	0.13376091	3.0785289509673257
SYSTEMIC SCLEROSIS	0.12696491	2.9221179131628277
CUSHING SYNDROME	0.12696465999999998	2.9221121593724435
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.12549925	2.8883855115047146
WHIPPLE DISEASE	0.12377978999999999	2.848811861848546
KALLMANN SYNDROME	0.12067368999999999	2.7773244685989065
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.11783925	2.712089374132371
KENNEDY DISEASE	0.11764569999999999	2.7076347896169115
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.11718690000000001	2.6970754335038007
PLAGUE	0.11588835	2.667189095490112
CONGENITAL MYASTHENIC SYNDROME	0.11350784	2.612401273300002
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.11350784	2.612401273300002
MICROSPORIDIOSIS	0.11228052000000001	2.584154305242584
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.11221465000000001	2.582638296552151
LEPTOSPIROSIS	0.11151131	2.566450812836816
PHELAN-MCDERMID SYNDROME	0.11121057000000001	2.559529233156221
ISOLATED SPINA BIFIDA	0.11111099999999999	2.5572376135219956
RAT-BITE FEVER	0.1093924	2.517683756904749
JUVENILE XANTHOGRANULOMA	0.10826446	2.491724035600864
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.10562342000000001	2.4309400733755564
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.10537634000000001	2.4252534872630296
ENCEPHALITIS LETHARGICA	0.10537634000000001	2.4252534872630296
AA AMYLOIDOSIS	0.10401606000000001	2.39394642332767
LEISHMANIASIS	0.1035461	2.3831302180118077
PRADER-WILLI SYNDROME	0.10232326	2.354986357878074
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.10163077000000001	2.3390485886654147
MYXOPAPILLARY EPENDYMOMA	0.1003015	2.308455224889313
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.1	2.30151615368595
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.1	2.30151615368595
NEUROFACIODIGITORENAL SYNDROME	0.1	2.30151615368595
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.1	2.30151615368595
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.1	2.30151615368595
LICHEN PLANUS PEMPHIGOIDES	0.1	2.30151615368595
ELLIS VAN CREVELD SYNDROME	0.1	2.30151615368595
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.1	2.30151615368595
WHIM SYNDROME	0.1	2.30151615368595
X-LINKED ADRENOLEUKODYSTROPHY	0.09972208	2.295119779991626
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.09965114000000001	2.2934870844322015
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.09965114	2.293487084432201
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.09550402000000001	2.1980404477194604
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.09491755	2.1845427459329385
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09491755	2.1845427459329385
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.093886	2.1608014560495907
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	0.09347830000000001	2.1514181746910137
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.09347830000000001	2.1514181746910137
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.09330630000000001	2.147459566906674
TETANUS	0.0909091	2.092287621670514
PROTEUS SYNDROME	0.0909091	2.092287621670514
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.0909091	2.092287621670514
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.0909091	2.092287621670514
AGEL AMYLOIDOSIS	0.09021816	2.0763855259582362
POSTPOLIOMYELITIS SYNDROME	0.08982925000000001	2.0674346994849366
MENINGIOMA	0.08843441000000002	2.0353322315668634
CRANIOPHARYNGIOMA	0.08843441000000002	2.0353322315668634
LEBER HEREDITARY OPTIC NEUROPATHY	0.08830427	2.032337038444456
CONE-ROD DYSTROPHY 2	0.0879433	2.024029255584496
PRADER-WILLI SYNDROME; PWS	0.08748268000000001	2.013428011877388
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0873949	2.011407740997682
HADDAD SYNDROME	0.08717945	2.006449124444566
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.08641972000000002	1.988963815770168
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0853608	1.9645926009155563
LAMBERT-EATON MYASTHENIC SYNDROME	0.08441560000000001	1.9428386702309168
ISOTRETINOIN-LIKE SYNDROME	0.08384615	1.929732686493752
PERRY SYNDROME	0.08333330000000001	1.917929360899574
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.08333330000000001	1.917929360899574
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.08333330000000001	1.917929360899574
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.08333330000000001	1.917929360899574
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.08333330000000001	1.917929360899574
OBESITY-HYPOVENTILATION SYNDROME	0.08333330000000001	1.917929360899574
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.08333330000000001	1.917929360899574
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0825032	1.8988244753078267
FRIEDREICH ATAXIA	0.08091095000000001	1.8621785843507623
CONE-ROD DYSTROPHY 10	0.0803653	1.8496203614581745
RETINITIS PUNCTATA ALBESCENS	0.0803653	1.8496203614581745
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.07827246	1.8014533107873736
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0779611	1.794287310091257
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.07746487	1.7828664964818215
OPTIC ATROPHY 5; OPA5	0.07692310000000001	1.7703975724159973
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.07692310000000001	1.7703975724159973
NEUROTROPHIC KERATOPATHY	0.07692310000000001	1.7703975724159973
NELSON SYNDROME	0.07692310000000001	1.7703975724159973
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.07692310000000001	1.7703975724159973
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	1.7703975724159973
AGNATHIA-OTOCEPHALY COMPLEX	0.07638890000000001	1.7581028731230068
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.07625018	1.7549102099146137
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.07565665	1.7412500210876414
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.07564100000000001	1.7408898338095897
PURE MITOCHONDRIAL MYOPATHY	0.07564100000000001	1.7408898338095897
MENKES DISEASE	0.0756038	1.7400336698004182
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.07493116	1.7245527515442651
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.07493116	1.7245527515442651
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.07388091	1.700381078140178
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0738095	1.6987375654548313
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.07235072000000001	1.6651635081080913
DOORS SYNDROME	0.07192891	1.6554554828202288
MULTIFOCAL MOTOR NEUROPATHY	0.0718105	1.6527302575426492
NOCARDIOSIS	0.07176199999999999	1.6516140222081113
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.07142860000000001	1.6439407673517228
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.07142860000000001	1.6439407673517228
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.07142860000000001	1.6439407673517228
ERYTHERMALGIA, PRIMARY	0.0703328	1.618720753339632
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.07019710000000001	1.6155975959190803
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.06911930000000001	1.5907918548146531
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.06708796	1.5440402365783688
OCCIPITAL HORN SYNDROME	0.06681903	1.537850769186261
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.0666667	1.5343448696293511
MICROTIA	0.0666667	1.5343448696293511
OTOMANDIBULAR SYNDROME	0.0666667	1.5343448696293511
RETINITIS PIGMENTOSA 58	0.0666667	1.5343448696293511
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.0666667	1.5343448696293511
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0666667	1.5343448696293511
XQ21 MICRODELETION SYNDROME	0.0666667	1.5343448696293511
THALIDOMIDE EMBRYOPATHY	0.0666667	1.5343448696293511
RETINITIS PIGMENTOSA 41	0.0666667	1.5343448696293511
VACTERL WITH HYDROCEPHALUS	0.0666667	1.5343448696293511
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.0666667	1.5343448696293511
HEMIFACIAL MICROSOMIA	0.0666667	1.5343448696293511
EAR-PATELLA-SHORT STATURE SYNDROME	0.0666667	1.5343448696293511
MONOSOMY 9P	0.0666667	1.5343448696293511
MICROTIA-ANOTIA	0.0666667	1.5343448696293511
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.0666667	1.5343448696293511
RETINITIS PIGMENTOSA 75; RP75	0.0666667	1.5343448696293511
CONE-ROD DYSTROPHY 6; CORD6	0.0666667	1.5343448696293511
JUVENILE GLAUCOMA	0.0666667	1.5343448696293511
CONE-ROD DYSTROPHY 8; CORD8	0.0666667	1.5343448696293511
MUCOPOLYSACCHARIDOSIS TYPE 2	0.0666667	1.5343448696293511
2Q23.1 MICRODUPLICATION SYNDROME	0.06658237	1.5324040010569477
SCHWARTZ-JAMPEL SYNDROME	0.06631311999999999	1.526207168813148
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0660461	1.5200616603795762
HYPERKALEMIC PERIODIC PARALYSIS	0.06594991	1.5178478319913458
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.06578941	1.5141538985646799
HELLP SYNDROME	0.0655701	1.5091064434880312
CLASSICAL EHLERS-DANLOS SYNDROME	0.06531945	1.5033376932488174
CRYPTOCOCCOSIS	0.064948	1.4947887114959508
SECONDARY POLYCYTHEMIA	0.06419984000000001	1.477569688240534
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.06321022000000001	1.4547934240804272
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06266965000000001	1.442352118208447
SMITH-MAGENIS SYNDROME; SMS	0.06251799000000001	1.438861638809767
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0625	1.4384475960537186
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0625	1.4384475960537186
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.0625	1.4384475960537186
KAPOSI SARCOMA	0.0623696	1.4354464189893121
HEPATOCELLULAR CARCINOMA	0.0623696	1.4354464189893121
HUNTINGTON DISEASE-LIKE 2	0.06227178	1.4331950758877765
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.06198806	1.4266652142565388
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.061970250000000004	1.4262553142295675
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.0616279	1.4183760736774236
ALG11-CDG	0.0615835	1.417354200505187
CHRONIC GRAFT VERSUS HOST DISEASE	0.0594276	1.3677358137478715
WHITE-SUTTON SYNDROME; WHSUS	0.05940175	1.3671408718221438
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.05940175	1.3671408718221438
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.0588235	1.3538323546634548
BILATERAL POLYMICROGYRIA	0.0588235	1.3538323546634548
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0588235	1.3538323546634548
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0588235	1.3538323546634548
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	1.3538323546634548
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0588235	1.3538323546634548
PROTEUS-LIKE SYNDROME	0.0588235	1.3538323546634548
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0588235	1.3538323546634548
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.0588235	1.3538323546634548
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	1.3538323546634548
MILROY DISEASE	0.0588235	1.3538323546634548
YELLOW NAIL SYNDROME	0.0588235	1.3538323546634548
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.0588235	1.3538323546634548
RING CHROMOSOME 22 SYNDROME	0.0588235	1.3538323546634548
BUTYRYLCHOLINESTERASE	0.0588235	1.3538323546634548
KLIPPEL-TRÉNAUNAY SYNDROME	0.0588235	1.3538323546634548
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0588235	1.3538323546634548
VON WILLEBRAND DISEASE	0.0588235	1.3538323546634548
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	1.3538323546634548
FAMILIAL MULTIPLE NEVI FLAMMEI	0.0588235	1.3538323546634548
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.0588235	1.3538323546634548
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0588235	1.3538323546634548
DERMOODONTODYSPLASIA	0.0588235	1.3538323546634548
ADULT SYNDROME	0.0588235	1.3538323546634548
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0588235	1.3538323546634548
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.0588235	1.3538323546634548
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0588235	1.3538323546634548
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.058612920000000006	1.348985821947023
SEVERE HEMOPHILIA A	0.05800794	1.3350621095204538
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.05687299999999999	1.3089412820858102
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.05687299999999999	1.3089412820858102
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.05687299999999999	1.3089412820858102
SPINOCEREBELLAR ATAXIA TYPE 18	0.05682582	1.3078554267645013
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.05678098	1.3068234269211885
CHOREOACANTHOCYTOSIS	0.05656368999999999	1.301822462470844
MACHADO-JOSEPH DISEASE; MJD	0.0565476	1.3014521485217163
MYOPATHIC EHLERS-DANLOS SYNDROME	0.05650757	1.3005308516053957
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.0561777	1.292938840269232
MYOTONIA FLUCTUANS	0.05591275999999999	1.286841203371656
17Q21.31 MICRODUPLICATION SYNDROME	0.055555600000000004	1.2786211082771517
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.2786211082771517
7P22.1 MICRODUPLICATION SYNDROME	0.055555600000000004	1.2786211082771517
WITTEVEEN-KOLK SYNDROME	0.055555600000000004	1.2786211082771517
POLAND SYNDROME	0.055555600000000004	1.2786211082771517
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.055555600000000004	1.2786211082771517
CHIME SYNDROME	0.055555600000000004	1.2786211082771517
ACROCRANIOFACIAL DYSOSTOSIS	0.055555600000000004	1.2786211082771517
3P25.3 MICRODELETION SYNDROME	0.055555600000000004	1.2786211082771517
WILDERVANCK SYNDROME	0.055555600000000004	1.2786211082771517
MYOPATHY, DISTAL, 5; MPD5	0.05520833	1.2706286331302463
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.05510620000000001	1.2682780946824872
GLYCEROL KINASE DEFICIENCY; GKD	0.05481221	1.2615118673422656
USHER SYNDROME	0.05476463	1.2604168059563419
FAMILIAL DYSAUTONOMIA	0.05367905	1.2354320068951579
19P13.3 MICRODUPLICATION SYNDROME	0.05345003	1.2301610745999865
INFANTILE MYOFIBROMATOSIS	0.0530914	1.2219071472180223
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.2113247759433743
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0526316	1.2113247759433743
LIGNEOUS CONJUNCTIVITIS	0.0526316	1.2113247759433743
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	0.0526316	1.2113247759433743
EHLERS-DANLOS SYNDROME, TYPE I	0.0526316	1.2113247759433743
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.0526316	1.2113247759433743
CONGENITAL FACTOR XIII DEFICIENCY	0.0526316	1.2113247759433743
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.0526316	1.2113247759433743
PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	0.0526316	1.2113247759433743
HEMOPHILIA B	0.0526316	1.2113247759433743
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0526316	1.2113247759433743
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.05208702	1.1987911792736314
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.05195045	1.1956479986625426
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.05179916	1.1921660348736312
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.051490770000000005	1.185068389207279
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.051339300000000004	1.181582282689291
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.05083084	1.1698799936542594
MYOTONIA PERMANENS	0.050704429999999995	1.1669706470843848
POTASSIUM-AGGRAVATED MYOTONIA	0.050704429999999995	1.1669706470843848
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.05066283	1.1660132163644514
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.05065892	1.1659232270828426
SPINOCEREBELLAR ATAXIA TYPE 14	0.05	1.150758076842975
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.05	1.150758076842975
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.05	1.150758076842975
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.04976094	1.1452560723259733
MERRF	0.04951463	1.1395872078878293
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.049404699999999996	1.1370571511800824
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.049330490000000005	1.1353491960424322
SANDIFER SYNDROME	0.04930065	1.1346624236221723
DUBOWITZ SYNDROME	0.04930065	1.1346624236221723
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.04840435	1.1140339343366852
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.04825306	1.1105519705477735
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0478831	1.1020372813855972
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.04775458	1.0990793728248798
SPINOCEREBELLAR ATAXIA TYPE 25	0.047494360000000006	1.0930903674897585
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.0473422	1.0895883805103097
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.04664286	1.0734929574411225
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.046531	1.0709184814716095
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.045956699999999996	1.0577008742009908
DISTAL TRISOMY 17Q	0.0454545	1.0461426600771802
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0454545	1.0461426600771802
MERCURY POISONING	0.0454545	1.0461426600771802
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0454545	1.0461426600771802
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0454545	1.0461426600771802
DUODENAL NEUROENDOCRINE TUMOR	0.0454545	1.0461426600771802
ILEAL NEUROENDOCRINE TUMOR	0.0454545	1.0461426600771802
JEJUNAL NEUROENDOCRINE TUMOR	0.0454545	1.0461426600771802
ADENOCARCINOMA OF OVARY	0.0454545	1.0461426600771802
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.04483857	1.0319669316317823
STEINERT MYOTONIC DYSTROPHY	0.0443063	1.019716651600558
THOMSEN AND BECKER DISEASE	0.0443063	1.019716651600558
GIANT CELL ARTERITIS	0.043946250000000006	1.0114300426892118
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.04388091999999999	1.0099264621860085
ADDISON DISEASE	0.04388091999999999	1.0099264621860085
ACUTE ADRENAL INSUFFICIENCY	0.04388091999999999	1.0099264621860085
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.043478300000000004	1.0006600978480384
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.043478300000000004	1.0006600978480384
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.043478300000000004	1.0006600978480384
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.043478300000000004	1.0006600978480384
DESMINOPATHY	0.043478300000000004	1.0006600978480384
SPINAL MUSCULAR ATROPHY, TYPE IV	0.043478300000000004	1.0006600978480384
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.042443749999999995	0.9768497624800803
CHERUBISM	0.04227	0.972850878163051
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.042239219999999994	0.9721424714909465
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.04219863	0.9712082860841653
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.042174100000000006	0.9706437241716664
OPTIC PATHWAY GLIOMA	0.04146636	0.9543549737455692
BECKER MUSCULAR DYSTROPHY	0.04097875	0.9431325508285812
MYOPATHY, SPHEROID BODY	0.04092263	0.9418409399631327
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.040815000000000004	0.9393638181269206
NEURONAL CEROID LIPOFUSCINOSIS	0.04052256	0.9326332642870812
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0401993	0.9251933831686762
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.03990658	0.9184563850836065
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.039560450000000004	0.9104901472208535
SPINOCEREBELLAR ATAXIA TYPE 4	0.03916258	0.9013331049001831
PRIMARY BILIARY CHOLANGITIS	0.03894548	0.8963365133305309
SPINOCEREBELLAR ATAXIA TYPE 34	0.038792799999999995	0.892822558467083
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.03866415	0.8898616579353662
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.038628	0.8890296598458087
CAP MYOPATHY	0.038628	0.8890296598458087
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.03853449	0.8868775120904969
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.03843094	0.8844942921133551
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.03839307	0.8836227079459543
GIANT AXONAL NEUROPATHY	0.03835877	0.8828332879052402
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.03835877	0.8828332879052402
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.8762953709674645
MELAS	0.03766612	0.8668918362667344
EPISODIC ATAXIA TYPE 1	0.03763444	0.8661627159492467
MUSCULAR DYSTROPHY, BARNES TYPE	0.037466429999999995	0.8622959386594388
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.03743265	0.8615184865027237
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.03742284	0.8612927077680471
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	0.03742284	0.8612927077680471
FAMILIAL HYPOALDOSTERONISM	0.037384970000000003	0.8604211236006463
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.03726890000000001	0.8577497538010632
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.03700946	0.8517787002919401
FAMILIAL COLORECTAL CANCER TYPE X	0.03693885	0.8501535997358226
LYNCH SYNDROME	0.036938849999999995	0.8501535997358225
FUNCTIONING GONADOTROPIC ADENOMA	0.03688132	0.8488295374926071
ADENOHYPOPHYSITIS	0.03662634	0.8429611316039386
PANHYPOPHYSITIS	0.03662634	0.8429611316039386
ATTRV30M AMYLOIDOSIS	0.0364583	0.8390936638592847
WOLF-HIRSCHHORN SYNDROME	0.03640748	0.8379240333499814
ATYPICAL RETT SYNDROME	0.03610425	0.8309451459171595
POLYMYOSITIS	0.03587573	0.8256857212027565
WILLIAMS SYNDROME	0.035836690000000004	0.8247872092963576
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.035804199999999994	0.8240394466980248
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.035714300000000004	0.8219703836758614
POSTERIOR MENINGOCELE	0.035714300000000004	0.8219703836758614
DISTAL MYOPATHY WITH ANTERIOR TIBIAL ONSET	0.035714300000000004	0.8219703836758614
OPTIC ATROPHY 2	0.035714300000000004	0.8219703836758614
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.035714300000000004	0.8219703836758614
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.035714300000000004	0.8219703836758614
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.035714300000000004	0.8219703836758614
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.035714300000000004	0.8219703836758614
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.035714300000000004	0.8219703836758614
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.035714300000000004	0.8219703836758614
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.035714300000000004	0.8219703836758614
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.035714300000000004	0.8219703836758614
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.03553379	0.8178159168668427
FLYNN-AIRD SYNDROME	0.035422659999999995	0.8152582419652514
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.035422659999999995	0.8152582419652514
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.03526606	0.8116540676685794
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.03526606	0.8116540676685794
MYOTONIC DYSTROPHY 1	0.035207949999999995	0.8103166566316723
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY	0.035207949999999995	0.8103166566316723
SANDHOFF DISEASE	0.035207949999999995	0.8103166566316723
EPISODIC ATAXIA, TYPE 2	0.035207949999999995	0.8103166566316723
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.035207949999999995	0.8103166566316723
GYRATE ATROPHY OF CHOROID AND RETINA	0.0349752	0.8049598777839683
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0349752	0.8049598777839683
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0349752	0.8049598777839683
SCLEROSTEOSIS 1; SOST1	0.0349174	0.8036296014471379
IATROGENIC BOTULISM	0.034796099999999996	0.8008378623527167
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.034788139999999995	0.8006546616668834
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.03472530000000001	0.7992083889159073
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.03472530000000001	0.7992083889159073
NEUTRAL LIPID STORAGE MYOPATHY	0.03472530000000001	0.7992083889159073
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03469828	0.7985865192511812
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.03469828	0.7985865192511812
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.03469828	0.7985865192511812
FABRY DISEASE	0.03453043	0.7947234243872194
LENNOX-GASTAUT SYNDROME	0.0344828	0.7936272122432187
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.0344828	0.7936272122432187
PERIORAL MYOCLONIA WITH ABSENCES	0.0344828	0.7936272122432187
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0344828	0.7936272122432187
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0344828	0.7936272122432187
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0344828	0.7936272122432187
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0344828	0.7936272122432187
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0344828	0.7936272122432187
BRAIN-LUNG-THYROID SYNDROME	0.0344828	0.7936272122432187
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	0.7936272122432187
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	0.7936272122432187
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	0.7936272122432187
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	0.7936272122432187
PROGRESSIVE SUPRANUCLEAR PALSY	0.0344828	0.7936272122432187
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	0.7936272122432187
ISOLATED GLYCEROL KINASE DEFICIENCY	0.03439291	0.7915583793726705
NEMALINE MYOPATHY 6	0.034297610000000006	0.7893650344782078
SANDHOFF DISEASE	0.03419985	0.7871150722863642
SHEEHAN SYNDROME	0.03419985	0.7871150722863642
BETHLEM MYOPATHY 2; BTHLM2	0.033799180000000005	0.777893587513391
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03377973	0.7774459426214989
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.033561179999999996	0.7724159790676182
PITUICYTOMA	0.03273194	0.753330886514793
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.03260339	0.7503722874992297
13Q12.3 MICRODELETION SYNDROME	0.03258746	0.7500056559759475
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.03241755	0.7460951498792198
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.03241755	0.7460951498792198
TURNPENNY-FRY SYNDROME; TPFS	0.03241755	0.7460951498792198
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.03241755	0.7460951498792198
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.03241755	0.7460951498792198
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.032344609999999996	0.744416423996721
PROXIMAL MYOTONIC MYOPATHY	0.0322581	0.7424253823721674
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0322581	0.7424253823721674
YOU-HOOVER-FONG SYNDROME; YHFS	0.0322581	0.7424253823721674
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0322581	0.7424253823721674
THROMBOCYTOPENIA 1	0.0322581	0.7424253823721674
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0322581	0.7424253823721674
TAY-SACHS DISEASE	0.0322581	0.7424253823721674
PYRIDOXINE-DEPENDENT EPILEPSY	0.0322581	0.7424253823721674
HYPERKALEMIC PERIODIC PARALYSIS; HYPP	0.0322581	0.7424253823721674
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	0.7424253823721674
SARCOSINEMIA	0.0322581	0.7424253823721674
HYDROXYKYNURENINURIA	0.0322581	0.7424253823721674
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.0322581	0.7424253823721674
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0322581	0.7424253823721674
LESCH-NYHAN SYNDROME	0.0322581	0.7424253823721674
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	0.7424253823721674
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	0.7424253823721674
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	0.7424253823721674
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0322581	0.7424253823721674
OXOGLUTARIC ACIDURIA	0.0322581	0.7424253823721674
DYSTROPHIA MYOTONICA 2	0.0322581	0.7424253823721674
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	0.7424253823721674
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	0.7424253823721674
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	0.7424253823721674
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	0.7424253823721674
NETHERTON SYNDROME; NETH	0.0322581	0.7424253823721674
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	0.7424253823721674
NORMOKALEMIC PERIODIC PARALYSIS	0.0322581	0.7424253823721674
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	0.7424253823721674
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.0322581	0.7424253823721674
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	0.7424253823721674
HUNTINGTON DISEASE	0.0322581	0.7424253823721674
ROWLEY-ROSENBERG SYNDROME	0.0322581	0.7424253823721674
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0322581	0.7424253823721674
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	0.7424253823721674
GRISCELLI SYNDROME TYPE 1	0.0322581	0.7424253823721674
DIENCEPHALIC SYNDROME	0.0322581	0.7424253823721674
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	0.7424253823721674
DESMOID TUMOR	0.0322581	0.7424253823721674
MYOTONIA, POTASSIUM-AGGRAVATED	0.0322581	0.7424253823721674
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	0.7424253823721674
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	0.7424253823721674
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	0.7424253823721674
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0322581	0.7424253823721674
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	0.7424253823721674
ISOLATED CEREBELLAR AGENESIS	0.0322581	0.7424253823721674
LEIGH SYNDROME	0.0322581	0.7424253823721674
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0322581	0.7424253823721674
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	0.7424253823721674
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	0.7424253823721674
WOLFRAM SYNDROME	0.03221447	0.7414212308743143
PEROXISOME BIOGENESIS DISORDER 5B	0.03189198	0.7339990714302924
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.03165782	0.7286098412048214
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.03143333	0.7234431675914118
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.03125	0.7192237980268593
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.03125	0.7192237980268593
PURE AUTONOMIC FAILURE	0.03125	0.7192237980268593
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.03125	0.7192237980268593
ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	0.03125	0.7192237980268593
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.03125	0.7192237980268593
PROLACTINOMA	0.030786479999999998	0.7085558103512942
TSH-SECRETING PITUITARY ADENOMA	0.030786479999999998	0.7085558103512942
NEURALGIC AMYOTROPHY	0.030623050000000002	0.7047944425013253
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.03045445	0.7009140862662108
ALEXANDER DISEASE	0.03041655	0.7000418116439638
ALSTROM SYNDROME; ALMS	0.02954106	0.6798922678700586
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.029516970000000003	0.6793378326286358
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0294118	0.6769173280898042
EAR MALFORMATION	0.0294118	0.6769173280898042
AREDYLD	0.0294118	0.6769173280898042
ALKAPTONURIA	0.0294118	0.6769173280898042
OTOONYCHOPERONEAL SYNDROME	0.0294118	0.6769173280898042
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	0.6769173280898042
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.6769173280898042
OSSIFIED EAR CARTILAGES	0.0294118	0.6769173280898042
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.6769173280898042
EAR WITHOUT HELIX	0.0294118	0.6769173280898042
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.6769173280898042
DARWINIAN POINT OF PINNA	0.0294118	0.6769173280898042
OSTEOMA OF MIDDLE EAR	0.0294118	0.6769173280898042
ROSSELLI-GULIENETTI SYNDROME	0.0294118	0.6769173280898042
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	0.6769173280898042
VELOCARDIOFACIAL SYNDROME	0.0294118	0.6769173280898042
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0294118	0.6769173280898042
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0294118	0.6769173280898042
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	0.6769173280898042
BLAU SYNDROME	0.0294118	0.6769173280898042
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	0.6769173280898042
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.6769173280898042
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.6769173280898042
EAR FOLDING	0.0294118	0.6769173280898042
EAR WAX, WET/DRY	0.0294118	0.6769173280898042
HAIRY EARS, Y-LINKED	0.0294118	0.6769173280898042
MUSICAL PERFECT PITCH	0.0294118	0.6769173280898042
FAMILIAL THROMBOCYTOSIS	0.02918584	0.6717168221889355
CRANIOSYNOSTOSIS 2	0.02918584	0.6717168221889355
LINEAR NEVUS SEBACEUS SYNDROME	0.029115999999999996	0.6701094433072011
CONGENITAL HYPOTHYROIDISM	0.029115999999999996	0.6701094433072011
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.02909776	0.6696896467607688
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.02909776	0.6696896467607688
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.028612	0.658509801892624
HURLER-SCHEIE SYNDROME	0.0285714	0.6575753863342275
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0285714	0.6575753863342275
HALLERMANN-STREIFF SYNDROME; HSS	0.0285714	0.6575753863342275
SCHEIE SYNDROME	0.0285714	0.6575753863342275
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.6575753863342275
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0285714	0.6575753863342275
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0285714	0.6575753863342275
DYSOSTEOSCLEROSIS	0.0285714	0.6575753863342275
MARSHALL-SMITH SYNDROME; MRSHSS	0.0285714	0.6575753863342275
ACHONDROPLASIA	0.0285714	0.6575753863342275
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0285714	0.6575753863342275
XIA-GIBBS SYNDROME	0.0285714	0.6575753863342275
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0285714	0.6575753863342275
COSTELLO SYNDROME; CSTLO	0.0285714	0.6575753863342275
APNEA, OBSTRUCTIVE SLEEP	0.0285714	0.6575753863342275
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0285635	0.6573935665580862
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.028483480000000002	0.6555518933319069
CENTRONUCLEAR MYOPATHY	0.028483480000000002	0.6555518933319069
NEUROLEPTIC MALIGNANT SYNDROME	0.028395459999999997	0.6535260988134324
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.02816527	0.6482282387792627
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.027795689999999998	0.6397222953784701
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.027795689999999998	0.6397222953784701
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.027765869999999998	0.6390359832614411
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.02768547	0.6371855642738775
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.02768547	0.6371855642738775
CENTRAL NEUROCYTOMA	0.027640309999999998	0.636146199578873
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.02708428	0.623349079309533
DYSAUTONOMIA-LIKE DISORDER	0.027006139999999998	0.6215506745870428
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.02686957	0.6184074939759538
SNEDDON SYNDROME	0.02675935	0.6158707628713612
BIOTINIDASE DEFICIENCY	0.02675935	0.6158707628713612
KID SYNDROME	0.026685599999999997	0.6141733947080178
NARP SYNDROME	0.02665294	0.613421719532224
NON-FUNCTIONING PITUITARY ADENOMA	0.026637099999999997	0.6130571593734802
CUSHING DISEASE	0.02654461	0.610928487082936
CEDNIK SYNDROME	0.026177809999999996	0.6024865258312159
BENIGN FAMILIAL INFANTILE EPILEPSY	0.025810069999999997	0.5940229303276512
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.025757490000000004	0.5928127931340432
ARACHNOIDITIS	0.025711369999999997	0.5917513338839632
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.025677329999999998	0.5909678977852485
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.025641000000000004	0.5901317569666146
SPINOCEREBELLAR ATAXIA TYPE 13	0.025641000000000004	0.5901317569666146
OSGOOD-SCHLATTER DISEASE	0.025641000000000004	0.5901317569666146
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.025641000000000004	0.5901317569666146
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.025641000000000004	0.5901317569666146
DISTAL ANOCTAMINOPATHY	0.025641000000000004	0.5901317569666146
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.025641000000000004	0.5901317569666146
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.025641000000000004	0.5901317569666146
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.025641000000000004	0.5901317569666146
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.025641000000000004	0.5901317569666146
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.02561382	0.5895062048760425
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.02558467	0.5888353129172431
METACHROMATIC LEUKODYSTROPHY	0.02555797	0.588220808104209
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.02553724	0.5877437038055499
CEREBROTENDINOUS XANTHOMATOSIS	0.025251689999999997	0.5811717244286996
MEDULLOBLASTOMA	0.02520991	0.5802101509796896
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.0250352	0.576189172107585
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0250352	0.576189172107585
KEARNS-SAYRE SYNDROME	0.0250352	0.576189172107585
PROXIMAL SPINAL MUSCULAR ATROPHY	0.0250352	0.576189172107585
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02493688	0.573926321425281
HYPERCALCEMIA, INFANTILE, 1	0.02484936	0.571912034487575
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.02476313	0.5699274371082517
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02467945	0.5680015283908472
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.02467945	0.5680015283908472
PITT-HOPKINS SYNDROME	0.02467945	0.5680015283908472
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.024614900000000002	0.5665158997136429
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.024614900000000002	0.5665158997136429
RETINAL CONE DYSTROPHY 4	0.02444116	0.5625172455482289
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.02428158	0.5588444860701769
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.02428158	0.5588444860701769
TRISOMY 20P	0.02428158	0.5588444860701769
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.02391972	0.5505162197164489
ADRENOLEUKODYSTROPHY	0.02388946	0.5498197809283436
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.023869370000000004	0.5493574063330681
MUSCLE-EYE-BRAIN DISEASE	0.023869370000000004	0.5493574063330681
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.0238095	0.5479794886118563
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	0.5479794886118563
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	0.5479794886118563
RETINITIS PIGMENTOSA 62; RP62	0.0238095	0.5479794886118563
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0238095	0.5479794886118563
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0238095	0.5479794886118563
RETINITIS PIGMENTOSA 78; RP78	0.0238095	0.5479794886118563
ISOLATED PLAGIOCEPHALY	0.0238095	0.5479794886118563
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0238095	0.5479794886118563
USHER SYNDROME, TYPE IIIA	0.0238095	0.5479794886118563
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0238095	0.5479794886118563
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0238095	0.5479794886118563
CAVITARY OPTIC DISC ANOMALIES; CODA	0.0238095	0.5479794886118563
RETINITIS PIGMENTOSA 4; RP4	0.0238095	0.5479794886118563
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.0238095	0.5479794886118563
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	0.5479794886118563
IDIOPATHIC UVEAL EFFUSION SYNDROME	0.0238095	0.5479794886118563
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0238095	0.5479794886118563
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.02379044	0.5475408196329636
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.02378315	0.54737303910536
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.02378315	0.54737303910536
INHERITED CREUTZFELDT-JAKOB DISEASE	0.02378315	0.54737303910536
RIFT VALLEY FEVER	0.02332187	0.5367566053916375
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.02314834	0.5327627844101462
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.023061569999999997	0.5307657588435929
PEROXISOME BIOGENESIS DISORDER 3B	0.0228608	0.5261450048618377
SUSAC SYNDROME	0.022725620000000002	0.523033815325285
XERODERMA PIGMENTOSUM	0.02270594	0.5225808769462396
CHYLOMICRON RETENTION DISEASE	0.02268449	0.522087201731274
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.02266553	0.5216508342685351
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.022608120000000002	0.520329533844704
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.02258739	0.5198524295460449
PEROXISOME BIOGENESIS DISORDER 14B	0.02245082	0.516709248934956
MYOPATHY, CONGENITAL	0.02244973	0.5166841624088808
CYSTINOSIS	0.02233318	0.5140017453317599
COFS SYNDROME	0.022324399999999998	0.5137996722134661
OSTEOPETROSIS AND RELATED DISORDERS	0.022301839999999996	0.5132804501691947
CONGENITAL DISORDER OF GLYCOSYLATION	0.022301839999999996	0.5132804501691947
MULTIPLE CARBOXYLASE DEFICIENCY	0.022263969999999998	0.5124088660017938
PARATHYROID CARCINOMA	0.022156640000000002	0.5099386487140427
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.022156640000000002	0.5099386487140427
PRIMARY PARATHYROID HYPERPLASIA	0.022156640000000002	0.5099386487140427
COCKAYNE SYNDROME A; CSA	0.022023130000000002	0.5068658944972566
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.02173941	0.5003360328660188
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.02166127	0.49853762814352853
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.02156081	0.4962255250155357
PREECLAMPSIA	0.021505339999999998	0.494948874005086
SICKLE CELL ANEMIA	0.02139078	0.4923122570994235
WILLIAMS-BEUREN SYNDROME; WBS	0.02132883	0.49088646784221496
CHERUBISM	0.0212766	0.4896843859551448
INFANTILE REFSUM DISEASE	0.0212766	0.4896843859551448
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 83; RP83	0.0212766	0.4896843859551448
CONE-ROD DYSTROPHY 20; CORD20	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 79	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 11	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 10; RP10	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 1	0.0212766	0.4896843859551448
BARDET-BIEDL SYNDROME 21; BBS21	0.0212766	0.4896843859551448
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 25; RP25	0.0212766	0.4896843859551448
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 14	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 6	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 72; RP72	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 19	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 73; RP73	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 74; RP74	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 13; RP13	0.0212766	0.4896843859551448
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA 69	0.0212766	0.4896843859551448
RETINITIS PIGMENTOSA	0.0212766	0.4896843859551448
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.0212766	0.4896843859551448
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	0.4896843859551448
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.02100134	0.4833492325905088
DISTAL MYOTILINOPATHY	0.02088716	0.48072136144623023
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.02083333	0.4794824553007011
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.0208333	0.479481764845855
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0208333	0.479481764845855
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.0208333	0.479481764845855
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.0208333	0.479481764845855
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0208333	0.479481764845855
CRANDALL SYNDROME	0.0208333	0.479481764845855
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0208333	0.479481764845855
PARKINSONIAN-PYRAMIDAL SYNDROME	0.0208333	0.479481764845855
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0208333	0.479481764845855
POLYARTERITIS NODOSA	0.0208333	0.479481764845855
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.479481764845855
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.479481764845855
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0208333	0.479481764845855
RAMOS-ARROYO SYNDROME	0.0208333	0.479481764845855
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.0208333	0.479481764845855
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0208333	0.479481764845855
ROMANO-WARD SYNDROME	0.0208333	0.479481764845855
611426 TENTED EYEBROWS	0.0208333	0.479481764845855
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.479481764845855
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0208333	0.479481764845855
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.0208333	0.479481764845855
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.479481764845855
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.479481764845855
PARKINSON DISEASE, LATE-ONSET; PD	0.0208333	0.479481764845855
PUPIL, EGG-SHAPED	0.0208333	0.479481764845855
STICKLER SYNDROME, TYPE III	0.0208333	0.479481764845855
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.479481764845855
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.479481764845855
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.479481764845855
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.479481764845855
GAUCHER DISEASE, TYPE I	0.0208333	0.479481764845855
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.479481764845855
IMINOGLYCINURIA	0.0208333	0.479481764845855
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.479481764845855
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.479481764845855
YOUNG-ONSET PARKINSON DISEASE	0.0208333	0.479481764845855
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0208333	0.479481764845855
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.479481764845855
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.479481764845855
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.479481764845855
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.479481764845855
UNIQUE GREEN PHENOMENON	0.0208333	0.479481764845855
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.479481764845855
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.479481764845855
DERMOIDS OF CORNEA	0.0208333	0.479481764845855
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.479481764845855
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.479481764845855
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY (ADLD)	0.0208333	0.479481764845855
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.479481764845855
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.479481764845855
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.479481764845855
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.479481764845855
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.479481764845855
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.020704810000000004	0.47652454673998407
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.02070481	0.47652454673998396
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.02070481	0.47652454673998396
BOUCHER-NEUHAUSER SYNDROME	0.020660989999999997	0.4755160223614387
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.020524419999999998	0.47237284175034977
CHROMOSOME 1P36 DELETION SYNDROME	0.02034401	0.468220676457485
FARBER DISEASE	0.02027838	0.46671019140582093
GERODERMA OSTEODYSPLASTICA	0.02027838	0.46671019140582093
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0202333	0.4656726679237393
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02019125	0.46470488038111435
GLIOBLASTOMA	0.02013675	0.46345055407735547
FONTAINE PROGEROID SYNDROME; FPS	0.0201293	0.4632790911239059
SIALIDOSIS TYPE 1	0.02009673	0.4625294873126505
CHARGE SYNDROME	0.019975149999999997	0.459731303972999
MYOPATHY, SCAPULOHUMEROPERONEAL	0.01994939	0.45913843341180954
REFSUM DISEASE	0.019871439999999997	0.45734440157001127
NATIVE AMERICAN MYOPATHY	0.019783000000000002	0.45530894068369154
WYBURN-MASON SYNDROME	0.019775769999999998	0.4551425410657799
WILSON DISEASE	0.01977438	0.4551105499912438
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.01977438	0.4551105499912438
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.019734869999999998	0.4542012209589224
INSULINOMA	0.019675099999999997	0.4528256047538643
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.019641060000000002	0.45204216865514973
DYSEQUILIBRIUM SYNDROME	0.01957728	0.4505742616523287
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.01950097	0.448817974675451
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.01950097	0.448817974675451
X-LINKED CENTRONUCLEAR MYOPATHY	0.019372450000000003	0.44586006611473394
CUTANEOUS MASTOCYTOSIS	0.01920679	0.4420473744545377
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.019121970000000002	0.44009522845298127
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.01907494	0.43901282540590275
LEGIONELLOSIS	0.01880376	0.43277157390033716
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.01871142	0.43064635388402356
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.01871142	0.43064635388402356
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.01871142	0.43064635388402356
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.01871142	0.43064635388402356
KRABBE DISEASE	0.018661040000000004	0.4294868500457967
NEMALINE MYOPATHY 3; NEM3	0.01859029	0.4278585273670638
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.01859029	0.4278585273670638
NEMALINE MYOPATHY 2; NEM2	0.01859029	0.4278585273670638
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.01859029	0.4278585273670638
INTERMEDIATE NEMALINE MYOPATHY	0.01859029	0.4278585273670638
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.01857485	0.4275031732729347
JUVENILE DERMATOMYOSITIS	0.018544150000000002	0.42679660781375317
ADULT POLYGLUCOSAN BODY DISEASE	0.018446330000000004	0.42454526471221754
MARINESCO-SJÖGREN SYNDROME	0.01834356	0.4221799965610744
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.01834356	0.4221799965610744
GRANULOMATOSIS WITH POLYANGIITIS	0.01822197	0.4193815830698077
LYME DISEASE	0.01800726	0.4144399977362286
COLD AGGLUTININ DISEASE	0.01800726	0.4144399977362286
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.01794553	0.4130192718145582
TOXIC EPIDERMAL NECROLYSIS	0.01794553	0.4130192718145582
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.01784798	0.41077414280663754
VON HIPPEL-LINDAU DISEASE	0.01784771	0.41076792871302265
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.01777445	0.40908183797883235
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.017544749999999998	0.40379525537381566
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.01748268	0.4023667042972228
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.01748268	0.4023667042972228
CRANIOECTODERMAL DYSPLASIA 1	0.01748268	0.4023667042972228
MOSAIC MONOSOMY X	0.01748268	0.4023667042972228
MONOSOMY X	0.01748268	0.4023667042972228
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.01748268	0.4023667042972228
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.01748268	0.4023667042972228
X SMALL RINGS	0.01748268	0.4023667042972228
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.01748268	0.4023667042972228
TURNER SYNDROME	0.01748268	0.4023667042972228
PMM2-CDG	0.0174247	0.4010322852313158
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.017256530000000003	0.39716182551566215
ADRENOMYODYSTROPHY	0.017256530000000003	0.39716182551566215
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.017256530000000003	0.39716182551566215
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.017256530000000003	0.39716182551566215
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.017256530000000003	0.39716182551566215
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.3968136061216094
TRANSSEXUALITY	0.0172414	0.3968136061216094
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.3968136061216094
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.3968136061216094
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.3968136061216094
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.3968136061216094
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.3968136061216094
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.3968136061216094
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.3968136061216094
DIASTEMATOMYELIA	0.0172414	0.3968136061216094
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.3968136061216094
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.3968136061216094
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.3968136061216094
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.3968136061216094
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.3968136061216094
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.3968136061216094
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.3968136061216094
JUMPING FRENCHMAN OF MAINE	0.0172414	0.3968136061216094
MOSAIC TRISOMY 15	0.0172414	0.3968136061216094
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.3968136061216094
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.3968136061216094
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.3968136061216094
269800 SENILE PLAQUE FORMATION	0.0172414	0.3968136061216094
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.3968136061216094
THUMBS, CONGENITAL CLASPED	0.0172414	0.3968136061216094
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.3968136061216094
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.3968136061216094
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.3968136061216094
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.3968136061216094
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.3968136061216094
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.3968136061216094
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.3968136061216094
CARDIAC ARRHYTHMIA	0.0172414	0.3968136061216094
CERVICAL RIB	0.0172414	0.3968136061216094
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.3968136061216094
RHEUMATOID ARTHRITIS	0.0172414	0.3968136061216094
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.3968136061216094
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.3968136061216094
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.3968136061216094
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.3968136061216094
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.3968136061216094
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.3968136061216094
ALCOHOL DEPENDENCE	0.0172414	0.3968136061216094
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.3968136061216094
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.3968136061216094
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.3968136061216094
PALMOMENTAL REFLEX	0.0172414	0.3968136061216094
MOTION SICKNESS	0.0172414	0.3968136061216094
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.01720927	0.39607412898143
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01717945	0.39538781686440094
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.01717945	0.39538781686440094
KLEEFSTRA SYNDROME	0.01717945	0.39538781686440094
CORNELIA DE LANGE SYNDROME 3	0.01717945	0.39538781686440094
HSD10 DISEASE	0.01714688	0.3946382130531454
BEHR SYNDROME	0.01714688	0.3946382130531454
CHYLOMICRON RETENTION DISEASE	0.01700306	0.3913281725209143
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.01700306	0.3913281725209143
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.01698138	0.39082920381879516
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.01686316	0.38810835142190764
NEURAMINIDASE DEFICIENCY	0.01664845	0.3831667660883285
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.016533100000000002	0.38051196720505187
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01649786	0.37970091291249286
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.01643528	0.3782606241035162
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.01643528	0.3782606241035162
KUSKOKWIM SYNDROME	0.01643528	0.3782606241035162
MULTIPLE SYMMETRIC LIPOMATOSIS	0.01643528	0.3782606241035162
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01643528	0.3782606241035162
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.01641972	0.37790250819000265
HEREDITARY FOLATE MALABSORPTION	0.01615396	0.3717859988599668
ABETALIPOPROTEINEMIA	0.01615156	0.3717307624722784
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.01615156	0.3717307624722784
ZELLWEGER SYNDROME	0.01615156	0.3717307624722784
CARTILAGE-HAIR HYPOPLASIA	0.01615156	0.3717307624722784
ALKAPTONURIA	0.016128999999999998	0.3712115404280068
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.3712115404280068
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.3712115404280068
FETAL PARVOVIRUS SYNDROME	0.016128999999999998	0.3712115404280068
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016128999999999998	0.3712115404280068
STERNAL CLEFT	0.016128999999999998	0.3712115404280068
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.016128999999999998	0.3712115404280068
CARDIOFACIOCUTANEOUS SYNDROME	0.016128999999999998	0.3712115404280068
DIPROSOPUS	0.016128999999999998	0.3712115404280068
MCCUNE-ALBRIGHT SYNDROME	0.016128999999999998	0.3712115404280068
ACRORENAL SYNDROME	0.016128999999999998	0.3712115404280068
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016128999999999998	0.3712115404280068
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.3712115404280068
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.016128999999999998	0.3712115404280068
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.016128999999999998	0.3712115404280068
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.016128999999999998	0.3712115404280068
WAARDENBURG SYNDROME	0.016128999999999998	0.3712115404280068
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.016128999999999998	0.3712115404280068
NARCOLEPSY TYPE 1	0.016128999999999998	0.3712115404280068
GORLIN-CHAUDHRY-MOSS SYNDROME	0.016128999999999998	0.3712115404280068
TRISOMY 13	0.016128999999999998	0.3712115404280068
RHOMBENCEPHALOSYNAPSIS	0.016128999999999998	0.3712115404280068
FETAL CYTOMEGALOVIRUS SYNDROME	0.016128999999999998	0.3712115404280068
ALG3-CDG	0.016128999999999998	0.3712115404280068
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.3712115404280068
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.3712115404280068
EEM SYNDROME	0.016128999999999998	0.3712115404280068
AMYLOIDOSIS	0.016128999999999998	0.3712115404280068
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016128999999999998	0.3712115404280068
MPDU1-CDG	0.016128999999999998	0.3712115404280068
HYPOPLASMINOGENEMIA	0.016128999999999998	0.3712115404280068
6Q25 MICRODELETION SYNDROME	0.016128999999999998	0.3712115404280068
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.016128999999999998	0.3712115404280068
DPM1-CDG	0.016128999999999998	0.3712115404280068
WAARDENBURG SYNDROME TYPE 1	0.016128999999999998	0.3712115404280068
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.016128999999999998	0.3712115404280068
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.016128999999999998	0.3712115404280068
X-LINKED RETINOSCHISIS	0.016128999999999998	0.3712115404280068
RECOMBINANT 8 SYNDROME	0.016128999999999998	0.3712115404280068
1P21.3 MICRODELETION SYNDROME	0.016128999999999998	0.3712115404280068
TOWNES-BROCKS SYNDROME	0.016128999999999998	0.3712115404280068
SILENT SINUS SYNDROME	0.016128999999999998	0.3712115404280068
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.016078679999999998	0.37005341749947207
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.01607342	0.3699323577497882
GLYCOGEN STORAGE DISEASE IV	0.01593685	0.3667891771386993
BRITTLE CORNEA SYNDROME	0.01586212	0.3650692541170498
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.015853660000000002	0.36487454585044804
ACROOSTEOLYSIS DOMINANT TYPE	0.01569856	0.3613048942960811
1P36 DELETION SYNDROME	0.01566732	0.36058590064966956
SYSTEMIC MASTOCYTOSIS	0.01566069	0.36043331012868024
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.01564396	0.3600482664761685
MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1	0.015625	0.35961189901342966
WERNICKE-KORSAKOFF SYNDROME	0.015625	0.35961189901342966
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.015625	0.35961189901342966
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.015625	0.35961189901342966
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.015625	0.35961189901342966
MONONEUROPATHY OF THE MEDIAN NERVE, MILD	0.015625	0.35961189901342966
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.015625	0.35961189901342966
WAARDENBURG-SHAH SYNDROME	0.015625	0.35961189901342966
46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY	0.015625	0.35961189901342966
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.015625	0.35961189901342966
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.015625	0.35961189901342966
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.015625	0.35961189901342966
APOLIPOPROTEIN A-I; APOA1	0.015625	0.35961189901342966
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.015625	0.35961189901342966
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.015625	0.35961189901342966
AMYLOIDOSIS, FINNISH TYPE	0.015625	0.35961189901342966
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.015625	0.35961189901342966
SPINOCEREBELLAR ATAXIA 23; SCA23	0.015625	0.35961189901342966
MACROPHAGIC MYOFASCIITIS	0.015594300000000002	0.35890533355424814
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.01553055	0.3574381170062733
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.01550387	0.35682407249646986
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.01550387	0.35682407249646986
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.01550387	0.35682407249646986
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.01550387	0.35682407249646986
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.015496480000000002	0.3566539904527125
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.015496480000000002	0.3566539904527125
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.015496480000000002	0.3566539904527125
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.015496480000000002	0.3566539904527125
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.015496480000000002	0.3566539904527125
XP21 MICRODELETION SYNDROME	0.015492680000000002	0.35656653283887246
NON-HISTAMINIC ANGIOEDEMA	0.01525766	0.35115750957447966
THYROTOXIC PERIODIC PARALYSIS	0.015134620000000001	0.34832572409898455
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.015134620000000001	0.34832572409898455
PERIPHERAL MOTOR NEUROPATHY-DYSAUTONOMIA SYNDROME	0.015134620000000001	0.34832572409898455
HODGKIN LYMPHOMA	0.015095279999999999	0.34742030764412446
NONAKA MYOPATHY	0.01507618	0.34698071805877045
FAMILIAL COLD URTICARIA	0.01505741	0.3465487234767236
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.01505741	0.3465487234767236
LASSA FEVER	0.01505741	0.3465487234767236
NIPAH VIRUS DISEASE	0.01505741	0.3465487234767236
MARBURG HEMORRHAGIC FEVER	0.01505741	0.3465487234767236
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.01505741	0.3465487234767236
EBOLA HEMORRHAGIC FEVER	0.01505741	0.3465487234767236
LUJO HEMORRHAGIC FEVER	0.01505741	0.3465487234767236
BABESIOSIS	0.01505741	0.3465487234767236
CARNEY TRIAD	0.01505741	0.3465487234767236
HUGHES-STOVIN SYNDROME	0.01505741	0.3465487234767236
SPINAL MUSCULAR ATROPHY, TYPE II	0.014998050000000002	0.3451825434878957
NEUROGENIC THORACIC OUTLET SYNDROME	0.014998050000000002	0.3451825434878957
THORACIC OUTLET SYNDROME	0.014998050000000002	0.3451825434878957
MONOMELIC AMYOTROPHY	0.014998050000000002	0.3451825434878957
ANTISYNTHETASE SYNDROME	0.014998050000000002	0.3451825434878957
L1 SYNDROME	0.01495959	0.344297380375188
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.01471432	0.3386524517050425
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.01471432	0.3386524517050425
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.01471432	0.3386524517050425
ADULT-ONSET NEMALINE MYOPATHY	0.01471432	0.3386524517050425
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.01471432	0.3386524517050425
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.01459773	0.33596911402146
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.01457775	0.33550927109395356
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.014467589999999999	0.3329739208990531
GITELMAN SYNDROME	0.01446116	0.33282593341037114
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0144373	0.3322767916561017
LEBER OPTIC ATROPHY AND DYSTONIA	0.0144373	0.3322767916561017
NIEMANN-PICK DISEASE, TYPE A	0.01420171	0.3268546497496329
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.01386832	0.31918162504485936
MASTOCYTOSIS	0.013830450000000001	0.3183100408774585
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.013830450000000001	0.3183100408774585
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.013830450000000001	0.3183100408774585
CLASSIC GALACTOSEMIA	0.01373263	0.3160586977759229
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.31527549182882353
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.31527549182882353
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.013698599999999998	0.31527549182882353
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.013698599999999998	0.31527549182882353
RETINAL CAPILLARY MALFORMATION	0.013698599999999998	0.31527549182882353
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.31527549182882353
CONE DYSTROPHY 3	0.013698599999999998	0.31527549182882353
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.013698599999999998	0.31527549182882353
KNOBLOCH SYNDROME	0.013698599999999998	0.31527549182882353
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.31527549182882353
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.31527549182882353
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.013698599999999998	0.31527549182882353
CHOROIDEREMIA	0.013698599999999998	0.31527549182882353
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.013698599999999998	0.31527549182882353
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.013698599999999998	0.31527549182882353
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.013698599999999998	0.31527549182882353
DONNAI-BARROW SYNDROME	0.013698599999999998	0.31527549182882353
ALSTRÖM SYNDROME	0.013698599999999998	0.31527549182882353
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.013698599999999998	0.31527549182882353
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.013698599999999998	0.31527549182882353
BASAL LAMINAR DRUSEN	0.013698599999999998	0.31527549182882353
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.31527549182882353
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.013698599999999998	0.31527549182882353
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.013698599999999998	0.31527549182882353
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.013698599999999998	0.31527549182882353
SENIOR-LOKEN SYNDROME	0.013698599999999998	0.31527549182882353
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.31527549182882353
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.013698599999999998	0.31527549182882353
RETINITIS PIGMENTOSA 80; RP80	0.013698599999999998	0.31527549182882353
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.013698599999999998	0.31527549182882353
CONE-ROD DYSTROPHY 16	0.013698599999999998	0.31527549182882353
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.013698599999999998	0.31527549182882353
JOUBERT SYNDROME 35; JBTS35	0.013698599999999998	0.31527549182882353
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.013698599999999998	0.31527549182882353
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.31527549182882353
ANIRIDIA 3	0.013698599999999998	0.31527549182882353
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.0136408	0.31394521549199306
MIXED CONNECTIVE TISSUE DISEASE	0.013565089999999998	0.3122027376120374
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.01349709	0.310637706627531
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.01346727	0.30995139451050185
GALACTOSEMIA	0.013448910000000001	0.3095288361446851
ATAXIA WITH VITAMIN E DEFICIENCY	0.01343866	0.30929293073893227
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.0133333	0.30686805331940875
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.0133333	0.30686805331940875
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.0133333	0.30686805331940875
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.0133333	0.30686805331940875
MICROPHTHALMIA, SYNDROMIC 1	0.0133333	0.30686805331940875
BARDET-BIEDL SYNDROME 2	0.0133333	0.30686805331940875
ADAMS-OLIVER SYNDROME 1; AOS1	0.0133333	0.30686805331940875
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.0133333	0.30686805331940875
ATRIAL SEPTAL DEFECT 1	0.0133333	0.30686805331940875
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0133333	0.30686805331940875
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.0133333	0.30686805331940875
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0133333	0.30686805331940875
SYNDROMIC DIARRHEA	0.0133333	0.30686805331940875
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.0133333	0.30686805331940875
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.0133333	0.30686805331940875
GRANGE SYNDROME; GRNG	0.0133333	0.30686805331940875
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0133333	0.30686805331940875
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0133333	0.30686805331940875
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.0133333	0.30686805331940875
FAMILIAL BICUSPID AORTIC VALVE	0.0133333	0.30686805331940875
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0133333	0.30686805331940875
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0133333	0.30686805331940875
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0133333	0.30686805331940875
AORTIC VALVE DISEASE 1; AOVD1	0.0133333	0.30686805331940875
LATERAL MENINGOCELE SYNDROME	0.0133333	0.30686805331940875
KOOLEN-DE VRIES SYNDROME; KDVS	0.0133333	0.30686805331940875
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.0133333	0.30686805331940875
DISTAL MONOSOMY 15Q	0.0133333	0.30686805331940875
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0133333	0.30686805331940875
HUNTER-MACDONALD SYNDROME	0.0133333	0.30686805331940875
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0133333	0.30686805331940875
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0133333	0.30686805331940875
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0133333	0.30686805331940875
PARTIAL ATRIOVENTRICULAR CANAL	0.0133333	0.30686805331940875
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0133333	0.30686805331940875
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.0133333	0.30686805331940875
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0133333	0.30686805331940875
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.0133333	0.30686805331940875
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.0133333	0.30686805331940875
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.0133333	0.30686805331940875
KOOLEN-DE VRIES SYNDROME	0.0133333	0.30686805331940875
AORTIC VALVE DISEASE 2; AOVD2	0.0133333	0.30686805331940875
AORTA COARCTATION	0.0133333	0.30686805331940875
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0133333	0.30686805331940875
AORTIC VALVE DISEASE 3; AOVD3	0.0133333	0.30686805331940875
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.01323855	0.3046873667637913
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.01321337	0.3041078449962932
DEND SYNDROME	0.013138750000000001	0.3023904536424128
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.01313523	0.302309440273803
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.01313523	0.302309440273803
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.01313523	0.302309440273803
SPONTANEOUS PERIODIC HYPOTHERMIA	0.01312935	0.30217411112396625
RHEUMATIC FEVER	0.01312935	0.30217411112396625
BEHÇET DISEASE	0.01312935	0.30217411112396625
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.012987	0.2988979028791943
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.012987	0.2988979028791943
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.012987	0.2988979028791943
MULIBREY NANISM	0.012987	0.2988979028791943
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.012987	0.2988979028791943
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.012987	0.2988979028791943
TETRASOMY 12P	0.012987	0.2988979028791943
GRISCELLI SYNDROME	0.012987	0.2988979028791943
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.012987	0.2988979028791943
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.012987	0.2988979028791943
ISOTRETINOIN SYNDROME	0.012987	0.2988979028791943
MADRAS MOTOR NEURON DISEASE	0.012987	0.2988979028791943
MAPLE SYRUP URINE DISEASE	0.012987	0.2988979028791943
POSTERIOR COLUMN ATAXIA	0.012987	0.2988979028791943
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.012987	0.2988979028791943
CAUDAL REGRESSION SEQUENCE	0.012987	0.2988979028791943
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.012987	0.2988979028791943
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.012987	0.2988979028791943
DPM3-CDG	0.012987	0.2988979028791943
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.012987	0.2988979028791943
SYMMETRICAL THALAMIC CALCIFICATIONS	0.012987	0.2988979028791943
RELAPSING FEVER	0.0129385	0.2977816675446567
ALPORT SYNDROME	0.0129385	0.2977816675446567
ACQUIRED METHEMOGLOBINEMIA	0.0129385	0.2977816675446567
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.01293097	0.2976083633782841
STEVENS-JOHNSON SYNDROME	0.01284563	0.2956442494927285
MALT LYMPHOMA	0.01284563	0.2956442494927285
ERDHEIM-CHESTER DISEASE	0.01284563	0.2956442494927285
PELIZAEUS-MERZBACHER DISEASE	0.01278568	0.29426449055859377
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.012700590000000001	0.2923061304634224
INHALATIONAL BOTULISM	0.01263092	0.2907026641591494
PORPHYRIA	0.01263092	0.2907026641591494
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.012570969999999999	0.28932290522501464
LOWRY-MACLEAN SYNDROME	0.012413839999999999	0.2857065328927279
SPONDYLO-OCULAR SYNDROME	0.012413839999999999	0.2857065328927279
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.01234225	0.28405887747830416
EPISODIC ATAXIA, TYPE 3	0.01234225	0.28405887747830416
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.01228725	0.2827930435937769
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.01228052	0.2826381515566338
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.01228052	0.2826381515566338
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.01228052	0.2826381515566338
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012209109999999999	0.2809946388712866
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	0.012209109999999999	0.2809946388712866
PERINEURAL CYST	0.01220216	0.2808346834986055
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.01217424	0.2801921001884964
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.01217072	0.28011108681988667
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.012140429999999999	0.27941395757693516
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.012140429999999999	0.27941395757693516
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.012140429999999999	0.27941395757693516
SEVERE CANAVAN DISEASE	0.012110609999999999	0.278727645459906
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.012110609999999999	0.278727645459906
MACHADO-JOSEPH DISEASE TYPE 3	0.012048200000000002	0.27729126922839065
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.012048200000000002	0.27729126922839065
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.012048200000000002	0.27729126922839065
MYHRE SYNDROME	0.012048200000000002	0.27729126922839065
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.012048200000000002	0.27729126922839065
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.012048200000000002	0.27729126922839065
BETHLEM MYOPATHY	0.012048200000000002	0.27729126922839065
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.012048200000000002	0.27729126922839065
HYPOKALEMIC PERIODIC PARALYSIS	0.012048200000000002	0.27729126922839065
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.012048200000000002	0.27729126922839065
GEMIGNANI SYNDROME	0.012048200000000002	0.27729126922839065
CERVICAL HYPERTRICHOSIS-PERIPHERAL NEUROPATHY SYNDROME	0.012048200000000002	0.27729126922839065
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.012048200000000002	0.27729126922839065
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.012048200000000002	0.27729126922839065
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.012048200000000002	0.27729126922839065
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.012048200000000002	0.27729126922839065
APOLIPOPROTEIN A-I DEFICIENCY	0.012048200000000002	0.27729126922839065
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.012048200000000002	0.27729126922839065
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.012048200000000002	0.27729126922839065
PRIMARY ORTHOSTATIC TREMOR	0.012048200000000002	0.27729126922839065
FACIOSCAPULOHUMERAL DYSTROPHY	0.012048200000000002	0.27729126922839065
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.012048200000000002	0.27729126922839065
MCLEOD SYNDROME; MCLDS	0.01203415	0.27696790620879774
MANGANESE POISONING	0.01198918	0.2759329143944852
POSTORGASMIC ILLNESS SYNDROME	0.01187229	0.2732426721624417
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.01187229	0.2732426721624417
AUTOIMMUNE HEMOLYTIC ANEMIA	0.01187229	0.2732426721624417
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.01187229	0.2732426721624417
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.01181056	0.27182194624077133
JOUBERT SYNDROME WITH OCULAR DEFECT	0.01171274	0.2695706031392357
MYOCLONIC EPILEPSY OF LAFORA	0.01171274	0.2695706031392357
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.01171274	0.2695706031392357
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.01171274	0.2695706031392357
SENGERS SYNDROME	0.011704280000000001	0.2693758948726339
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.01170428	0.2693758948726339
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.0116279	0.2676179968344486
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.0116279	0.2676179968344486
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0116279	0.2676179968344486
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0116279	0.2676179968344486
MYOPATHY, DISTAL 3	0.0116279	0.2676179968344486
TUBULAR AGGREGATE MYOPATHY	0.0116279	0.2676179968344486
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.0116279	0.2676179968344486
SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM	0.0116279	0.2676179968344486
DISTAL NEBULIN MYOPATHY	0.0116279	0.2676179968344486
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0116279	0.2676179968344486
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.0116279	0.2676179968344486
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.0116279	0.2676179968344486
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0116279	0.2676179968344486
DISTAL MYOPATHY, WELANDER TYPE	0.0116279	0.2676179968344486
GLYCOGEN STORAGE DISEASE WITH SEVERE CARDIOMYOPATHY DUE TO GLYCOGENIN DEFICIENCY	0.0116279	0.2676179968344486
AMISH NEMALINE MYOPATHY	0.0116279	0.2676179968344486
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0116279	0.2676179968344486
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.0116279	0.2676179968344486
MICROFORM HOLOPROSENCEPHALY	0.0116279	0.2676179968344486
TIBIAL MUSCULAR DYSTROPHY	0.0116279	0.2676179968344486
NEMALINE MYOPATHY 1; NEM1	0.0116279	0.2676179968344486
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.0116279	0.2676179968344486
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0116279	0.2676179968344486
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.0116279	0.2676179968344486
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0116279	0.2676179968344486
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.011606459999999999	0.2671245517710983
AMERICAN TRYPANOSOMIASIS	0.01154918	0.265806243318267
NEUROFIBROMATOSIS, TYPE II	0.01154918	0.265806243318267
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.01154918	0.265806243318267
HEMANGIOBLASTOMA	0.01151131	0.2649346591508661
PAPILLARY TUMOR OF THE PINEAL REGION	0.01151131	0.2649346591508661
DENGUE FEVER	0.01151131	0.2649346591508661
INDOLENT SYSTEMIC MASTOCYTOSIS	0.01151131	0.2649346591508661
SCRUB TYPHUS	0.01151131	0.2649346591508661
YELLOW FEVER	0.01151131	0.2649346591508661
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.01151131	0.2649346591508661
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.01151131	0.2649346591508661
LHERMITTE-DUCLOS DISEASE	0.01151131	0.2649346591508661
PAROXYSMAL COLD HEMOGLOBINURIA	0.01151131	0.2649346591508661
RHABDOID TUMOR	0.01151131	0.2649346591508661
MALARIA	0.01151131	0.2649346591508661
PINEOCYTOMA	0.01151131	0.2649346591508661
CENTRAL DIABETES INSIPIDUS	0.01151131	0.2649346591508661
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.01145931	0.2637378707509494
HENNEKAM-BEEMER SYNDROME	0.01143813	0.2632504096295987
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.01142902	0.26304074150799794
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.01142902	0.26304074150799794
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.01142902	0.26304074150799794
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01142902	0.26304074150799794
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.01138117	0.26193946602845924
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.01138117	0.26193946602845924
CARCINOID SYNDROME	0.0113433	0.2610678818610584
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.0113433	0.2610678818610584
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01131049	0.26031275441103396
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.01131049	0.26031275441103396
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0112446	0.2587962854173703
MYOPATHY, DISTAL, 4; MPD4	0.011244599999999999	0.25879628541737026
SPINOCEREBELLAR ATAXIA TYPE 7	0.01121431	0.25809915617441886
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.01121431	0.25809915617441886
PEROXISOME BIOGENESIS DISORDER 11B	0.01121431	0.25809915617441886
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.01121431	0.25809915617441886
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01111529	0.25582019487903906
NAVAJO NEUROHEPATOPATHY	0.010978449999999999	0.25267080017433513
OSTEOGENESIS IMPERFECTA	0.01076222	0.24769423179522004
ACTH-DEPENDENT CUSHING SYNDROME	0.010645330000000001	0.24500398956317657
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.010645330000000001	0.24500398956317657
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.01064533	0.2450039895631765
GITELMAN SYNDROME	0.01051201	0.24193560822708243
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.01045899	0.24071534436239814
ROUSSY-LÉVY SYNDROME	0.01041067	0.23960325175693709
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.01041067	0.23960325175693709
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.01041067	0.23960325175693709
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.01041067	0.23960325175693709
SMITH-MAGENIS SYNDROME	0.01038085	0.23891693963990793
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.01032222	0.23756756071900187
FLYNN-AIRD SYNDROME	0.01032222	0.23756756071900187
NIEMANN-PICK DISEASE TYPE B	0.01032222	0.23756756071900187
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.01032222	0.23756756071900187
ROTHMUND-THOMSON SYNDROME	0.010284350000000001	0.23669597655160102
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0102741	0.23646007114584816
BETA-THALASSEMIA MAJOR	0.01026379	0.23622278483040318
PORPHYRIA VARIEGATA	0.0101889	0.2344991793829078
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.0101889	0.2344991793829078
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.01009713	0.23238707800867014
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.01004881	0.2312749854032091
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.01004881	0.2312749854032091
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01004881	0.2312749854032091
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.01004881	0.2312749854032091
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.01004881	0.2312749854032091
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.01004881	0.2312749854032091
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.01001899	0.23058867328617996
CORNELIA DE LANGE SYNDROME	0.01001899	0.23058867328617996
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00998112	0.22971708911877908
ADENOCARCINOMA OF THE ESOPHAGUS	0.00998112	0.22971708911877908
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00998112	0.22971708911877908
MONOSOMY 22Q13.3	0.00998112	0.22971708911877908
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00994423	0.22886805980968433
WALKER-WARBURG SYNDROME	0.00991224	0.22813180479212017
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00991224	0.22813180479212017
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00991224	0.22813180479212017
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00991224	0.22813180479212017
WALDENSTRÖM MACROGLOBULINEMIA	0.009718939999999999	0.22368297406704526
SARCOIDOSIS	0.009718939999999999	0.22368297406704526
SCHNITZLER SYNDROME	0.009718939999999999	0.22368297406704526
CLASSIC HODGKIN LYMPHOMA	0.009718939999999999	0.22368297406704526
WISKOTT-ALDRICH SYNDROME	0.009718939999999999	0.22368297406704526
COCKAYNE SYNDROME	0.009718939999999999	0.22368297406704526
GAMMA-HEAVY CHAIN DISEASE	0.009718939999999999	0.22368297406704526
MALIGNANT ATROPHIC PAPULOSIS	0.00968107	0.2228113898996444
BOTULISM	0.00968107	0.2228113898996444
AMYOTROPHIC LATERAL SCLEROSIS	0.00968107	0.2228113898996444
CASTLEMAN DISEASE	0.00968107	0.2228113898996444
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00968107	0.2228113898996444
VIRAL HEMORRHAGIC FEVER	0.00968107	0.2228113898996444
LIPOSARCOMA	0.00968107	0.2228113898996444
GASTROINTESTINAL STROMAL TUMOR	0.00968107	0.2228113898996444
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00968107	0.2228113898996444
KAWASAKI DISEASE	0.00968107	0.2228113898996444
PITUITARY APOPLEXY	0.00968107	0.2228113898996444
CINCA SYNDROME	0.00968107	0.2228113898996444
PFAPA SYNDROME	0.00968107	0.2228113898996444
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00968107	0.2228113898996444
MAST SYNDROME	0.00962112	0.22143163096550966
MOEBIUS SYNDROME; MBS	0.00962112	0.22143163096550966
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00962112	0.22143163096550966
OCULODENTODIGITAL DYSPLASIA	0.00956269	0.220086855076911
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00948455	0.21828845035442077
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00948455	0.21828845035442077
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.0093924	0.2161676032187992
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0093924	0.2161676032187992
TURCOT SYNDROME WITH POLYPOSIS	0.0093924	0.2161676032187992
BENIGN OCCIPITAL EPILEPSY	0.0093924	0.2161676032187992
HYPER-IGD SYNDROME	0.0093924	0.2161676032187992
PAPILLOMA OF CHOROID PLEXUS	0.0093924	0.2161676032187992
POSTENCEPHALITIC PARKINSONISM	0.0093924	0.2161676032187992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.00935771	0.2153692072650855
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0093374	0.21490176933427188
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0093374	0.21490176933427188
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.00925926	0.2131033646117817
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00925926	0.2131033646117817
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00925926	0.2131033646117817
TRICHOTHIODYSTROPHY	0.00925926	0.2131033646117817
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00922249	0.21225709712207136
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00920083	0.211758588723183
STIFF SKIN SYNDROME	0.00912269	0.20996018400069277
IMMUNOGLOBULIN A VASCULITIS	0.00908482	0.20908859983329192
PORPHYRIA VARIEGATA	0.00908482	0.20908859983329192
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00908482	0.20908859983329192
ATYPICAL TERATOID RHABDOID TUMOR	0.00908482	0.20908859983329192
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0090843	0.20907663194929274
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00905448	0.20839031983226358
POLYCYTHEMIA VERA	0.00892244	0.2053513979029367
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00892244	0.2053513979029367
PRIMARY FAMILIAL POLYCYTHEMIA	0.00892244	0.2053513979029367
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00892244	0.2053513979029367
PONTIAC FEVER	0.00892244	0.2053513979029367
TYPHOID	0.00892244	0.2053513979029367
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.00892244	0.2053513979029367
ADIPOSIS DOLOROSA	0.00892244	0.2053513979029367
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00882462	0.2031000548014011
RIDDLE SYNDROME	0.00882462	0.2031000548014011
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00875443	0.20148462061312894
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.00875443	0.20148462061312894
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00865661	0.1992332775115933
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00865661	0.1992332775115933
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00865661	0.1992332775115933
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00865661	0.1992332775115933
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00865661	0.1992332775115933
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0085409	0.19657019317016333
NEUROFIBROMATOSIS TYPE 1	0.0085409	0.19657019317016333
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00837289	0.19270341588035553
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00832619	0.19162860783658422
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00832619	0.19162860783658422
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00832619	0.19162860783658422
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00832619	0.19162860783658422
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00832619	0.19162860783658422
CAMURATI-ENGELMANN DISEASE	0.00832619	0.19162860783658422
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00832619	0.19162860783658422
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00829475	0.19090501115786532
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00829475	0.19090501115786532
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00829475	0.19090501115786532
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00829475	0.19090501115786532
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00829475	0.19090501115786532
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00829475	0.19090501115786532
TYPICAL NEMALINE MYOPATHY	0.00829475	0.19090501115786532
RIGID SPINE SYNDROME	0.00829475	0.19090501115786532
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00826446	0.19020788191491383
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.19020788191491383
X-LINKED CORNEAL DERMOID	0.00826446	0.19020788191491383
WEILL-MARCHESANI SYNDROME	0.00826446	0.19020788191491383
CATARACT 7; CTRCT7	0.00826446	0.19020788191491383
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.00826446	0.19020788191491383
PFEIFFER SYNDROME TYPE 2	0.00826446	0.19020788191491383
NANCE-HORAN SYNDROME	0.00826446	0.19020788191491383
STICKLER SYNDROME TYPE 1	0.00826446	0.19020788191491383
BLAU SYNDROME	0.00826446	0.19020788191491383
RETINOSCHISIS OF FOVEA	0.00826446	0.19020788191491383
KNOBLOCH SYNDROME 1; KNO1	0.00826446	0.19020788191491383
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00826446	0.19020788191491383
NEOVASCULAR GLAUCOMA	0.00826446	0.19020788191491383
BIRDSHOT CHORIORETINOPATHY	0.00826446	0.19020788191491383
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00826446	0.19020788191491383
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00826446	0.19020788191491383
OPTICOCOCHLEODENTATE DEGENERATION	0.00826446	0.19020788191491383
USHER SYNDROME TYPE 1	0.00826446	0.19020788191491383
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00826446	0.19020788191491383
CONGENITAL GLAUCOMA	0.00826446	0.19020788191491383
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.00826446	0.19020788191491383
USHER SYNDROME TYPE 2	0.00826446	0.19020788191491383
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.19020788191491383
USHER SYNDROME TYPE 3	0.00826446	0.19020788191491383
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00826446	0.19020788191491383
SRD5A3-CDG	0.00826446	0.19020788191491383
BRITTLE CORNEA SYNDROME	0.00826446	0.19020788191491383
MOHR-TRANEBJAERG SYNDROME	0.00826446	0.19020788191491383
TYROSINEMIA TYPE 2	0.00826446	0.19020788191491383
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00826446	0.19020788191491383
PEHO SYNDROME	0.00826446	0.19020788191491383
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.19020788191491383
NANCE-HORAN SYNDROME	0.00826446	0.19020788191491383
CATARACT 44; CTRCT44	0.00826446	0.19020788191491383
OPTIC ATROPHY 8	0.00826446	0.19020788191491383
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00826446	0.19020788191491383
SENIOR-LOKEN SYNDROME 3	0.00826446	0.19020788191491383
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00826446	0.19020788191491383
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00826446	0.19020788191491383
LATE-ONSET RETINAL DEGENERATION; LORD	0.00826446	0.19020788191491383
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.19020788191491383
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00826446	0.19020788191491383
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.00826446	0.19020788191491383
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00826446	0.19020788191491383
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.19020788191491383
UVEAL MELANOMA	0.00826446	0.19020788191491383
ISOLATED ANIRIDIA	0.00826446	0.19020788191491383
ECTODERMAL DYSPLASIA SYNDROME	0.00826446	0.19020788191491383
NEUROMYELITIS OPTICA	0.00826446	0.19020788191491383
LCAT DEFICIENCY	0.00826446	0.19020788191491383
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00826446	0.19020788191491383
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00826446	0.19020788191491383
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00826446	0.19020788191491383
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.00826446	0.19020788191491383
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00826446	0.19020788191491383
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00826446	0.19020788191491383
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00816544	0.18792892061953403
PROPIONIC ACIDEMIA	0.00816544	0.18792892061953403
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00816544	0.18792892061953403
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00816544	0.18792892061953403
LYSINURIC PROTEIN INTOLERANCE	0.00816544	0.18792892061953403
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00816544	0.18792892061953403
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00816544	0.18792892061953403
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00816544	0.18792892061953403
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00816544	0.18792892061953403
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00815818	0.18776183054677642
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.00815818	0.18776183054677642
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00815818	0.18776183054677642
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00815818	0.18776183054677642
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00815818	0.18776183054677642
CHANARIN-DORFMAN SYNDROME	0.00815818	0.18776183054677642
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00815818	0.18776183054677642
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00815818	0.18776183054677642
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00802535	0.1847047266398354
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00799553	0.18401841452280626
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00799553	0.18401841452280626
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00789203	0.18163634530374126
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00789203	0.18163634530374126
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00789203	0.18163634530374126
SSR4-CDG	0.00786221	0.18095003318671213
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00786221	0.18095003318671213
MÉNÉTRIER DISEASE	0.00786221	0.18095003318671213
ESOPHAGEAL ATRESIA	0.00786221	0.18095003318671213
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00786221	0.18095003318671213
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00786221	0.18095003318671213
CITRULLINEMIA TYPE I	0.00786221	0.18095003318671213
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00786221	0.18095003318671213
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00786221	0.18095003318671213
ADNP SYNDROME	0.00786221	0.18095003318671213
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00786221	0.18095003318671213
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00772212	0.17772583920701346
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00772212	0.17772583920701346
OCULOCEREBRORENAL SYNDROME OF LOWE	0.00772212	0.17772583920701346
RARE HEREDITARY HEMOCHROMATOSIS	0.00769548	0.17711271530367154
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00769548	0.17711271530367154
PRIMARY SCLEROSING CHOLANGITIS	0.00769548	0.17711271530367154
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.007597660000000001	0.17486137220213596
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.007597660000000001	0.17486137220213596
WOLCOTT-RALLISON SYNDROME	0.007597660000000001	0.17486137220213596
SPONASTRIME DYSPLASIA	0.007597660000000001	0.17486137220213596
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00756216	0.17404433396757743
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00756216	0.17404433396757743
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.00756216	0.17404433396757743
INHALATIONAL ANTHRAX	0.00756216	0.17404433396757743
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.00756216	0.17404433396757743
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.00746434	0.17179299086604183
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.00746434	0.17179299086604183
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.00746434	0.17179299086604183
EPENDYMOMA	0.00746434	0.17179299086604183
SUBEPENDYMOMA	0.00746434	0.17179299086604183
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00746434	0.17179299086604183
REYNOLDS SYNDROME	0.0073922499999999995	0.17013382787084963
ARTERIAL TORTUOSITY SYNDROME	0.0073922499999999995	0.17013382787084963
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00732425	0.1685687968863432
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00732425	0.1685687968863432
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00732425	0.1685687968863432
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00732425	0.1685687968863432
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00732425	0.1685687968863432
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00732425	0.1685687968863432
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00732425	0.1685687968863432
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00731394	0.16833151057089815
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.00731394	0.16833151057089815
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00731394	0.16833151057089815
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.00731394	0.16833151057089815
MARFAN SYNDROME	0.00731394	0.16833151057089815
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00731394	0.16833151057089815
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00729443	0.16788248476931406
TENORIO SYNDROME; TNORS	0.00729443	0.16788248476931406
HEREDITARY HYPEREKPLEXIA	0.00729443	0.16788248476931406
16P13.2 MICRODELETION SYNDROME	0.00729443	0.16788248476931406
3Q29 MICRODELETION SYNDROME	0.00729443	0.16788248476931406
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00718062	0.16526312923480407
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00718062	0.16526312923480407
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0071024799999999996	0.16346472451231386
SECONDARY SHORT BOWEL SYNDROME	0.0071024799999999996	0.16346472451231386
BETA-KETOTHIOLASE DEFICIENCY	0.0071024799999999996	0.16346472451231386
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00709923	0.16338992523731904
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00709923	0.16338992523731904
HEMOCHROMATOSIS TYPE 2	0.00709923	0.16338992523731904
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00709923	0.16338992523731904
SIALIDOSIS TYPE 2	0.00709923	0.16338992523731904
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00709923	0.16338992523731904
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00709923	0.16338992523731904
EPIDERMAL NEVUS SYNDROME	0.00704053	0.1620389352551054
LOWE OCULOCEREBRORENAL SYNDROME	0.00704053	0.1620389352551054
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00704053	0.1620389352551054
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00704053	0.1620389352551054
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00704053	0.1620389352551054
HEART AND BRAIN MALFORMATION SYNDROME	0.00701071	0.16135262313807625
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00701071	0.16135262313807625
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00701071	0.16135262313807625
BAKER-GORDON SYNDROME; BAGOS	0.00701071	0.16135262313807625
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.00699438	0.16097678555017933
GAUCHER DISEASE TYPE 3	0.00699438	0.16097678555017933
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.00699438	0.16097678555017933
CYCLIC VOMITING SYNDROME	0.0069659100000000005	0.16032154390122497
VALINEMIA	0.0069659100000000005	0.16032154390122497
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0069659100000000005	0.16032154390122497
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0069659100000000005	0.16032154390122497
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.0069659100000000005	0.16032154390122497
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00696239	0.1602405305326152
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00696239	0.1602405305326152
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.00696239	0.1602405305326152
SPINOCEREBELLAR ATAXIA 18	0.00696239	0.1602405305326152
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00696239	0.1602405305326152
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	0.00696239	0.1602405305326152
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.00696239	0.1602405305326152
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.00696239	0.1602405305326152
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.00696239	0.1602405305326152
SPINOCEREBELLAR ATAXIA TYPE 43	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00696239	0.1602405305326152
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.00696239	0.1602405305326152
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00696239	0.1602405305326152
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00696239	0.1602405305326152
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00696239	0.1602405305326152
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB	0.00696239	0.1602405305326152
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00696239	0.1602405305326152
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00696239	0.1602405305326152
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	0.00696239	0.1602405305326152
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00696239	0.1602405305326152
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00696239	0.1602405305326152
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00696239	0.1602405305326152
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00696239	0.1602405305326152
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.00696239	0.1602405305326152
DE SANCTIS-CACCHIONE SYNDROME	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	0.00696239	0.1602405305326152
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00696239	0.1602405305326152
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.00693257	0.15955421841558606
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.00693257	0.15955421841558606
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.00693257	0.15955421841558606
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00693257	0.15955421841558606
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00693257	0.15955421841558606
PITT-HOPKINS-LIKE SYNDROME	0.00693257	0.15955421841558606
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00682582	0.15709734992152632
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00682582	0.15709734992152632
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00682582	0.15709734992152632
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.00682582	0.15709734992152632
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00682582	0.15709734992152632
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00682582	0.15709734992152632
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00682582	0.15709734992152632
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00682582	0.15709734992152632
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00682582	0.15709734992152632
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00682582	0.15709734992152632
HOLOPROSENCEPHALY	0.006796	0.15641103780449714
MUCOLIPIDOSIS TYPE III	0.00671066	0.15444692391894158
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00671066	0.15444692391894158
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00671066	0.15444692391894158
ATYPICAL JUVENILE PARKINSONISM	0.006632519999999999	0.15264851919645134
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00661284	0.15219558081740597
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00661284	0.15219558081740597
NEUROFIBROMATOSIS TYPE 2	0.00661284	0.15219558081740597
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00661284	0.15219558081740597
2P15P16.1 MICRODELETION SYNDROME	0.00661284	0.15219558081740597
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00661284	0.15219558081740597
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00661284	0.15219558081740597
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00661284	0.15219558081740597
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00661284	0.15219558081740597
CADASIL	0.00661284	0.15219558081740597
INCONTINENTIA PIGMENTI	0.00661284	0.15219558081740597
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00661284	0.15219558081740597
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00661284	0.15219558081740597
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.0065347	0.15039717609491576
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0065347	0.15039717609491576
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0065347	0.15039717609491576
METACHROMATIC LEUKODYSTROPHY	0.0065347	0.15039717609491576
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.00649595	0.14950533858536247
X-LINKED SIDEROBLASTIC ANEMIA	0.00649595	0.14950533858536247
EISENMENGER SYNDROME	0.00649595	0.14950533858536247
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00649595	0.14950533858536247
ACTH-INDEPENDENT CUSHING SYNDROME	0.00649595	0.14950533858536247
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00649595	0.14950533858536247
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.00649595	0.14950533858536247
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.00649595	0.14950533858536247
TAKAYASU ARTERITIS	0.00649595	0.14950533858536247
MYXEDEMA	0.00649595	0.14950533858536247
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00649595	0.14950533858536247
LIDDLE SYNDROME	0.00649595	0.14950533858536247
EVANS SYNDROME	0.00649595	0.14950533858536247
ACUTE PROMYELOCYTIC LEUKEMIA	0.00649595	0.14950533858536247
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00649595	0.14950533858536247
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.00649595	0.14950533858536247
ATHYREOSIS	0.00649595	0.14950533858536247
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00639813	0.14725399548382687
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00639813	0.14725399548382687
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00639813	0.14725399548382687
COFFIN-LOWRY SYNDROME	0.00639813	0.14725399548382687
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00639813	0.14725399548382687
PEROXISOME BIOGENESIS DISORDER 6B	0.00625098	0.14386731446367798
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00625098	0.14386731446367798
TANGIER DISEASE; TGD	0.00625098	0.14386731446367798
MICRO SYNDROME	0.00617284	0.14206890974118777
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.00617284	0.14206890974118777
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.00617284	0.14206890974118777
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00617284	0.14206890974118777
RABSON-MENDENHALL SYNDROME	0.00617284	0.14206890974118777
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.00617284	0.14206890974118777
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00617284	0.14206890974118777
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.00617284	0.14206890974118777
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.00617284	0.14206890974118777
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.00617284	0.14206890974118777
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00617284	0.14206890974118777
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.00617284	0.14206890974118777
MACHADO-JOSEPH DISEASE TYPE 2	0.00617284	0.14206890974118777
PRIMARY ERYTHROMELALGIA	0.00617284	0.14206890974118777
MEDNIK SYNDROME	0.00617284	0.14206890974118777
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.00617284	0.14206890974118777
FOLATE MALABSORPTION, HEREDITARY	0.00617284	0.14206890974118777
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.00617284	0.14206890974118777
FELTY SYNDROME	0.00617284	0.14206890974118777
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00617284	0.14206890974118777
CRANIAL NERVES, RECURRENT PARESIS OF	0.00617284	0.14206890974118777
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00617284	0.14206890974118777
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00617284	0.14206890974118777
SPINOCEREBELLAR ATAXIA TYPE 11	0.00617284	0.14206890974118777
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00617284	0.14206890974118777
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.00617284	0.14206890974118777
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00617284	0.14206890974118777
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.00617284	0.14206890974118777
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00617284	0.14206890974118777
NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE	0.00617284	0.14206890974118777
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00617284	0.14206890974118777
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.00617284	0.14206890974118777
CARPAL TUNNEL SYNDROME	0.00617284	0.14206890974118777
SÉZARY SYNDROME	0.00617284	0.14206890974118777
PRIMARY HYPEROXALURIA	0.00617284	0.14206890974118777
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00617284	0.14206890974118777
DISORDER OF BILE ACID SYNTHESIS	0.00617284	0.14206890974118777
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00617284	0.14206890974118777
NEUROPATHY, PAINFUL	0.00617284	0.14206890974118777
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00617284	0.14206890974118777
THALIDOMIDE SUSCEPTIBILITY	0.00617284	0.14206890974118777
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00617284	0.14206890974118777
IRIDA SYNDROME	0.00617284	0.14206890974118777
MACHADO-JOSEPH DISEASE TYPE 1	0.00617284	0.14206890974118777
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00617284	0.14206890974118777
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00617284	0.14206890974118777
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.00617284	0.14206890974118777
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00617284	0.14206890974118777
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00617284	0.14206890974118777
ACRODYSOSTOSIS	0.00617284	0.14206890974118777
FAMILIAL MULTIPLE LIPOMATOSIS	0.00617284	0.14206890974118777
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.00617284	0.14206890974118777
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.00613497	0.14119732557378692
ACUTE INTERMITTENT PORPHYRIA	0.00613497	0.14119732557378692
HEREDITARY COPROPORPHYRIA	0.00613497	0.14119732557378692
HYDATIDIFORM MOLE	0.00613497	0.14119732557378692
CLASSIC PHENYLKETONURIA	0.00613497	0.14119732557378692
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00613497	0.14119732557378692
PSEUDOMYXOMA PERITONEI	0.00613497	0.14119732557378692
GALACTOSE EPIMERASE DEFICIENCY	0.00613497	0.14119732557378692
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00613497	0.14119732557378692
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00613497	0.14119732557378692
FAMILIAL PAROXYSMAL ATAXIA	0.00613497	0.14119732557378692
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.14119732557378692
FAMILIAL MEDITERRANEAN FEVER	0.00613497	0.14119732557378692
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.00613497	0.14119732557378692
GRFOMA	0.00613497	0.14119732557378692
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00613497	0.14119732557378692
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00613497	0.14119732557378692
SOMATOSTATINOMA	0.00613497	0.14119732557378692
VIPOMA	0.00613497	0.14119732557378692
CREST SYNDROME	0.00613497	0.14119732557378692
GLUCAGONOMA	0.00613497	0.14119732557378692
PPOMA	0.00613497	0.14119732557378692
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.14119732557378692
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00613497	0.14119732557378692
GRISCELLI SYNDROME TYPE 2	0.00613497	0.14119732557378692
NEPHROGENIC DIABETES INSIPIDUS	0.00613497	0.14119732557378692
RECURRENT ACUTE PANCREATITIS	0.00613497	0.14119732557378692
PRIMARY PERITONEAL CARCINOMA	0.00613497	0.14119732557378692
EPISODIC ATAXIA TYPE 6	0.00613497	0.14119732557378692
RABIES	0.00613497	0.14119732557378692
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00613497	0.14119732557378692
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00613497	0.14119732557378692
BURKITT LYMPHOMA	0.00613497	0.14119732557378692
PEDIATRIC-ONSET GRAVES DISEASE	0.00613497	0.14119732557378692
INTESTINAL BOTULISM	0.00613497	0.14119732557378692
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00613497	0.14119732557378692
HALL-RIGGS SYNDROME	0.00613497	0.14119732557378692
PAROXYSMAL HEMICRANIA	0.00613497	0.14119732557378692
FAMILIAL PANCREATIC CARCINOMA	0.00613497	0.14119732557378692
DRACUNCULIASIS	0.00613497	0.14119732557378692
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.00613497	0.14119732557378692
CHOLESTERYL ESTER STORAGE DISEASE	0.00613497	0.14119732557378692
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.00613497	0.14119732557378692
WOLMAN DISEASE	0.00613497	0.14119732557378692
HIRSCHSPRUNG DISEASE	0.00613497	0.14119732557378692
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00613497	0.14119732557378692
FOODBORNE BOTULISM	0.00613497	0.14119732557378692
MICROSCOPIC POLYANGIITIS	0.00613497	0.14119732557378692
NEUROENDOCRINE TUMOR OF STOMACH	0.00613497	0.14119732557378692
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00611441	0.14072413385258908
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00611441	0.14072413385258908
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00611441	0.14072413385258908
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00603627	0.13892572913009887
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.00603627	0.13892572913009887
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.00603627	0.13892572913009887
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00603627	0.13892572913009887
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00603627	0.13892572913009887
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00603627	0.13892572913009887
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00603627	0.13892572913009887
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00603627	0.13892572913009887
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00603627	0.13892572913009887
SNEDDON SYNDROME	0.00537634	0.1237373335770792
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.1237373335770792
CROUZON DISEASE	0.00537634	0.1237373335770792
PARKES WEBER SYNDROME	0.00537634	0.1237373335770792
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00537634	0.1237373335770792
PARIETAL FORAMINA	0.00537634	0.1237373335770792
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00537634	0.1237373335770792
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.1237373335770792
THYMIC TUMOR	0.00537634	0.1237373335770792
INTERNAL CAROTID AGENESIS	0.00537634	0.1237373335770792
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00537634	0.1237373335770792
BRUNNER SYNDROME; BRNRS	0.00537634	0.1237373335770792
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.1237373335770792
PITUITARY CARCINOMA	0.00537634	0.1237373335770792
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00537634	0.1237373335770792
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.1237373335770792
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.00537634	0.1237373335770792
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.1237373335770792
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.1237373335770792
SYDENHAM CHOREA	0.00537634	0.1237373335770792
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.1237373335770792
GANGLIOCYTOMA	0.00537634	0.1237373335770792
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.1237373335770792
MARSILI SYNDROME; MARSIS	0.00537634	0.1237373335770792
CUTANEOUS MASTOCYTOMA	0.00537634	0.1237373335770792
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.1237373335770792
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00537634	0.1237373335770792
AICARDI-GOUTIÈRES SYNDROME	0.00537634	0.1237373335770792
MAJEED SYNDROME	0.00537634	0.1237373335770792
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00537634	0.1237373335770792
ROSAÏ-DORFMAN DISEASE	0.00537634	0.1237373335770792
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.1237373335770792
15Q OVERGROWTH SYNDROME	0.00537634	0.1237373335770792
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.00537634	0.1237373335770792
SOLAR URTICARIA	0.00537634	0.1237373335770792
IDIOPATHIC PANUVEITIS	0.00537634	0.1237373335770792
PRIMARY CILIARY DYSKINESIA	0.00537634	0.1237373335770792
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00537634	0.1237373335770792
PINEOBLASTOMA	0.00537634	0.1237373335770792
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.1237373335770792
LAFORA DISEASE	0.00537634	0.1237373335770792
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.00537634	0.1237373335770792
HYDROXYKYNURENINURIA	0.00537634	0.1237373335770792
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.1237373335770792
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.1237373335770792
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.1237373335770792
TEMPI SYNDROME	0.00537634	0.1237373335770792
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00537634	0.1237373335770792
PRIMARY LIPODYSTROPHY	0.00520833	0.11987055628727143
300270 ADRENOMYODYSTROPHY	0.00520833	0.11987055628727143
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00520833	0.11987055628727143
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00520833	0.11987055628727143
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00520833	0.11987055628727143
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00520833	0.11987055628727143
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00520833	0.11987055628727143
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00520833	0.11987055628727143
STROMME SYNDROME; STROMS	0.00520833	0.11987055628727143
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00520833	0.11987055628727143
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00520833	0.11987055628727143
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00520833	0.11987055628727143
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00520833	0.11987055628727143
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00520833	0.11987055628727143
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.00520833	0.11987055628727143
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00520833	0.11987055628727143
CENTRAL CORE DISEASE	0.00520833	0.11987055628727143
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00520833	0.11987055628727143
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00520833	0.11987055628727143
DISTAL MYOPATHY	0.00520833	0.11987055628727143
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00520833	0.11987055628727143
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00520833	0.11987055628727143
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00520833	0.11987055628727143
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00520833	0.11987055628727143
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00520833	0.11987055628727143
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00520833	0.11987055628727143
HYPOPHOSPHATASIA, CHILDHOOD	0.00520833	0.11987055628727143
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.00520833	0.11987055628727143
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00520833	0.11987055628727143
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00520833	0.11987055628727143
VICI SYNDROME; VICIS	0.00520833	0.11987055628727143
XANTHINURIA, TYPE I	0.00520833	0.11987055628727143
ACQUIRED PARTIAL LIPODYSTROPHY	0.00520833	0.11987055628727143
ADDUCTED THUMBS SYNDROME	0.00520833	0.11987055628727143
MARINESCO-SJOGREN SYNDROME; MSS	0.00520833	0.11987055628727143
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00520833	0.11987055628727143
CAREY-FINEMAN-ZITER SYNDROME	0.00520833	0.11987055628727143
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00520833	0.11987055628727143
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00520833	0.11987055628727143
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00520833	0.11987055628727143
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00520833	0.11987055628727143
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00520833	0.11987055628727143
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00520833	0.11987055628727143
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00520833	0.11987055628727143
AXIAL OSTEOMALACIA	0.00520833	0.11987055628727143
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.00520833	0.11987055628727143
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00520833	0.11987055628727143
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00520833	0.11987055628727143
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00520833	0.11987055628727143
SANJAD-SAKATI SYNDROME	0.00520833	0.11987055628727143
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00520833	0.11987055628727143
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00520833	0.11987055628727143
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00520833	0.11987055628727143
BETHLEM MYOPATHY 1	0.00520833	0.11987055628727143
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00520833	0.11987055628727143
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00520833	0.11987055628727143
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00520833	0.11987055628727143
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00520833	0.11987055628727143
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00520833	0.11987055628727143
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	0.00520833	0.11987055628727143
B4GALT1-CDG	0.00520833	0.11987055628727143
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00520833	0.11987055628727143
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00520833	0.11987055628727143
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.00520833	0.11987055628727143
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00520833	0.11987055628727143
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.00520833	0.11987055628727143
CARNITINE DEFICIENCY, MYOPATHIC	0.00520833	0.11987055628727143
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00520833	0.11987055628727143
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00520833	0.11987055628727143
FINGERPRINT BODY MYOPATHY	0.00520833	0.11987055628727143
CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH	0.00520833	0.11987055628727143
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00520833	0.11987055628727143
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00520833	0.11987055628727143
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00520833	0.11987055628727143
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00520833	0.11987055628727143
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00520833	0.11987055628727143
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00520833	0.11987055628727143
SALIH MYOPATHY; SALMY	0.00520833	0.11987055628727143
IMMUNODEFICIENCY 9; IMD9	0.00520833	0.11987055628727143
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.00520833	0.11987055628727143
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00520833	0.11987055628727143
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.00520833	0.11987055628727143
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00520833	0.11987055628727143
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00520833	0.11987055628727143
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00520833	0.11987055628727143
VACUOLAR MYOPATHY WITH SARCOPLASMIC RETICULUM PROTEIN AGGREGATES	0.00520833	0.11987055628727143
STORMORKEN SYNDROME; STRMK	0.00520833	0.11987055628727143
CRANIOECTODERMAL DYSPLASIA	0.00414938	0.09549865097781407
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00414938	0.09549865097781407
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00414938	0.09549865097781407
AMISH LETHAL MICROCEPHALY	0.00414938	0.09549865097781407
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00414938	0.09549865097781407
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00414938	0.09549865097781407
MU-HEAVY CHAIN DISEASE	0.00414938	0.09549865097781407
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00414938	0.09549865097781407
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00414938	0.09549865097781407
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00414938	0.09549865097781407
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00414938	0.09549865097781407
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00414938	0.09549865097781407
EHLERS-DANLOS SYNDROME, TYPE VI	0.00414938	0.09549865097781407
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00414938	0.09549865097781407
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00414938	0.09549865097781407
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.00414938	0.09549865097781407
LICHTENSTEIN SYNDROME	0.00414938	0.09549865097781407
GERODERMA OSTEODYSPLASTICUM; GO	0.00414938	0.09549865097781407
ODONTOCHONDRODYSPLASIA; ODCD	0.00414938	0.09549865097781407
GLYCOGEN STORAGE DISEASE IA	0.00414938	0.09549865097781407
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00414938	0.09549865097781407
GLYCOGEN STORAGE DISEASE IB	0.00414938	0.09549865097781407
OVARIAN DYSGENESIS 1	0.00414938	0.09549865097781407
DYSKERATOSIS CONGENITA	0.00414938	0.09549865097781407
AFRICAN IRON OVERLOAD	0.00414938	0.09549865097781407
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00414938	0.09549865097781407
HEMOCHROMATOSIS, TYPE 1	0.00414938	0.09549865097781407
EXTENSOR TENDONS OF FINGER ANOMALIES	0.00414938	0.09549865097781407
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00414938	0.09549865097781407
CLEIDOCRANIAL DYSPLASIA	0.00414938	0.09549865097781407
OVARIAN DYSGENESIS 8; ODG8	0.00414938	0.09549865097781407
OSTEOPOROSIS	0.00414938	0.09549865097781407
CLASSIC HOMOCYSTINURIA	0.00414938	0.09549865097781407
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00414938	0.09549865097781407
601220 OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH	0.00414938	0.09549865097781407
LATHOSTEROLOSIS	0.00414938	0.09549865097781407
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00414938	0.09549865097781407
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00414938	0.09549865097781407
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00414938	0.09549865097781407
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00414938	0.09549865097781407
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00414938	0.09549865097781407
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00414938	0.09549865097781407
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00414938	0.09549865097781407
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00414938	0.09549865097781407
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00414938	0.09549865097781407
MYCETOMA	0.00414938	0.09549865097781407
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00414938	0.09549865097781407
WARBURG MICRO SYNDROME 1	0.00414938	0.09549865097781407
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00414938	0.09549865097781407
FRANK-TER HAAR SYNDROME; FTHS	0.00414938	0.09549865097781407
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00414938	0.09549865097781407
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00414938	0.09549865097781407
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00414938	0.09549865097781407
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00414938	0.09549865097781407
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00414938	0.09549865097781407
MENKES DISEASE	0.00414938	0.09549865097781407
ESTROGEN RESISTANCE SYNDROME	0.00414938	0.09549865097781407
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	0.00414938	0.09549865097781407
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	0.00414938	0.09549865097781407
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00414938	0.09549865097781407
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00414938	0.09549865097781407
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00414938	0.09549865097781407
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00414938	0.09549865097781407
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00414938	0.09549865097781407
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00414938	0.09549865097781407
MACS SYNDROME	0.00414938	0.09549865097781407
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00414938	0.09549865097781407
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.00414938	0.09549865097781407
BETA-THALASSEMIA INTERMEDIA	0.00414938	0.09549865097781407
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.00414938	0.09549865097781407
FORSYTHE-WAKELING SYNDROME; FWS	0.00414938	0.09549865097781407
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00414938	0.09549865097781407
ATYPICAL WERNER SYNDROME	0.00414938	0.09549865097781407
LOEYS-DIETZ SYNDROME 3; LDS3	0.00414938	0.09549865097781407
46,XY PARTIAL GONADAL DYSGENESIS	0.00414938	0.09549865097781407
IDIOPATHIC HYPERCALCIURIA	0.00414938	0.09549865097781407
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.00414938	0.09549865097781407
WERNER SYNDROME; WRN	0.00414938	0.09549865097781407
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00414938	0.09549865097781407
AROMATASE DEFICIENCY	0.00414938	0.09549865097781407
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00414938	0.09549865097781407
FAMILIAL HYPERPROLACTINEMIA	0.00414938	0.09549865097781407
URBAN-ROGERS-MEYER SYNDROME	0.00414938	0.09549865097781407
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.00414938	0.09549865097781407
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00414938	0.09549865097781407
BRUCK SYNDROME	0.00414938	0.09549865097781407
OSTEOPOROSIS, JUVENILE	0.00414938	0.09549865097781407
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00414938	0.09549865097781407
PRIMROSE SYNDROME; PRIMS	0.00414938	0.09549865097781407
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00414938	0.09549865097781407
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00414938	0.09549865097781407
THROMBOCYTOPENIA 6	0.00414938	0.09549865097781407
PACHYDERMOPERIOSTOSIS	0.00414938	0.09549865097781407
JUVENILE PAGET DISEASE	0.00414938	0.09549865097781407
SHASHI-PENA SYNDROME; SHAPNS	0.00414938	0.09549865097781407
MORQUIO SYNDROME A	0.00414938	0.09549865097781407
DESBUQUOIS DYSPLASIA 1	0.00414938	0.09549865097781407
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00414938	0.09549865097781407
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.00414938	0.09549865097781407
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00414938	0.09549865097781407
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00414938	0.09549865097781407
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00414938	0.09549865097781407
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00414938	0.09549865097781407
INFANTILE SYSTEMIC HYALINOSIS	0.00414938	0.09549865097781407
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00414938	0.09549865097781407
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00414938	0.09549865097781407
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00414938	0.09549865097781407
NEU-LAXOVA SYNDROME	0.00414938	0.09549865097781407
PREMATURE OVARIAN FAILURE 2B	0.00414938	0.09549865097781407
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00414938	0.09549865097781407
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00414938	0.09549865097781407
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	0.00414938	0.09549865097781407
WERNER SYNDROME	0.00414938	0.09549865097781407
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.00414938	0.09549865097781407
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00401606	0.09243026964171996
ENTERIC ANENDOCRINOSIS	0.00401606	0.09243026964171996
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.00401606	0.09243026964171996
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.09243026964171996
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00401606	0.09243026964171996
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00401606	0.09243026964171996
HEREDITARY FRUCTOSE INTOLERANCE	0.00401606	0.09243026964171996
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00401606	0.09243026964171996
PANCREATOBLASTOMA	0.00401606	0.09243026964171996
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.00401606	0.09243026964171996
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.00401606	0.09243026964171996
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00401606	0.09243026964171996
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00401606	0.09243026964171996
GRAFT VERSUS HOST DISEASE	0.00401606	0.09243026964171996
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00401606	0.09243026964171996
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00401606	0.09243026964171996
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.00401606	0.09243026964171996
19P13.13 MICRODELETION SYNDROME	0.00401606	0.09243026964171996
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00401606	0.09243026964171996
HISTIOCYTOID CARDIOMYOPATHY	0.00401606	0.09243026964171996
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00401606	0.09243026964171996
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.00401606	0.09243026964171996
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.00401606	0.09243026964171996
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00401606	0.09243026964171996
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00401606	0.09243026964171996
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00401606	0.09243026964171996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00401606	0.09243026964171996
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00401606	0.09243026964171996
KRABBE DISEASE	0.00401606	0.09243026964171996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00401606	0.09243026964171996
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.09243026964171996
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.09243026964171996
HYPOPHOSPHATASIA, INFANTILE	0.00401606	0.09243026964171996
HYPOADRENOCORTICISM, FAMILIAL	0.00401606	0.09243026964171996
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00401606	0.09243026964171996
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00401606	0.09243026964171996
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.09243026964171996
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00401606	0.09243026964171996
HYPERLIPOPROTEINEMIA, TYPE I	0.00401606	0.09243026964171996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.00401606	0.09243026964171996
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00401606	0.09243026964171996
MOWAT-WILSON SYNDROME; MOWS	0.00401606	0.09243026964171996
HEREDITARY ANGIOEDEMA TYPE 1	0.00401606	0.09243026964171996
GALACTOSEMIA	0.00401606	0.09243026964171996
GALACTOSE EPIMERASE DEFICIENCY	0.00401606	0.09243026964171996
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.00401606	0.09243026964171996
ISOLATED COMPLEX I DEFICIENCY	0.00401606	0.09243026964171996
MAPLE SYRUP URINE DISEASE; MSUD	0.00401606	0.09243026964171996
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.00401606	0.09243026964171996
CITRULLINEMIA TYPE II	0.00401606	0.09243026964171996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00401606	0.09243026964171996
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00401606	0.09243026964171996
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00401606	0.09243026964171996
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00401606	0.09243026964171996
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.09243026964171996
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00401606	0.09243026964171996
COLCHICINE POISONING	0.00401606	0.09243026964171996
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00401606	0.09243026964171996
CONGENITAL SHORT BOWEL SYNDROME	0.00401606	0.09243026964171996
ATRESIA OF SMALL INTESTINE	0.00401606	0.09243026964171996
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00401606	0.09243026964171996
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00401606	0.09243026964171996
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00401606	0.09243026964171996
EOSINOPHILIC GASTROENTERITIS	0.00401606	0.09243026964171996
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00401606	0.09243026964171996
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00401606	0.09243026964171996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00401606	0.09243026964171996
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00401606	0.09243026964171996
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.09243026964171996
CAROLI DISEASE, ISOLATED	0.00401606	0.09243026964171996
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.00401606	0.09243026964171996
METHYLMALONIC ACIDURIA, CBLA TYPE	0.00401606	0.09243026964171996
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00401606	0.09243026964171996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.00401606	0.09243026964171996
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.00401606	0.09243026964171996
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.09243026964171996
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00401606	0.09243026964171996
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00401606	0.09243026964171996
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00401606	0.09243026964171996
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00401606	0.09243026964171996
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00401606	0.09243026964171996
PORPHYRIA, ACUTE HEPATIC	0.00401606	0.09243026964171996
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.00401606	0.09243026964171996
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00401606	0.09243026964171996
EPISODIC ATAXIA, TYPE 6	0.00401606	0.09243026964171996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00401606	0.09243026964171996
LARYNGOTRACHEAL ANGIOMA	0.00401606	0.09243026964171996
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.00401606	0.09243026964171996
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00401606	0.09243026964171996
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00401606	0.09243026964171996
ANGIOEDEMA, HEREDITARY, TYPE III	0.00401606	0.09243026964171996
CONGENITAL PANCREATIC CYST	0.00401606	0.09243026964171996
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00401606	0.09243026964171996
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00401606	0.09243026964171996
MEVALONIC ACIDURIA; MEVA	0.00401606	0.09243026964171996
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00401606	0.09243026964171996
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00401606	0.09243026964171996
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00401606	0.09243026964171996
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00401606	0.09243026964171996
VISCERAL MYOPATHY; VSCM	0.00401606	0.09243026964171996
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00401606	0.09243026964171996
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00401606	0.09243026964171996
ACID PHOSPHATASE DEFICIENCY	0.00401606	0.09243026964171996
CITRULLINEMIA, CLASSIC	0.00401606	0.09243026964171996
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00401606	0.09243026964171996
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00401606	0.09243026964171996
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.00401606	0.09243026964171996
ARGININOSUCCINIC ACIDURIA	0.00401606	0.09243026964171996
INFANTILE LIVER FAILURE SYNDROME 2	0.00401606	0.09243026964171996
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00401606	0.09243026964171996
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00401606	0.09243026964171996
ALPHA-METHYLACETOACETIC ACIDURIA	0.00401606	0.09243026964171996
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00401606	0.09243026964171996
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00401606	0.09243026964171996
PEUTZ-JEGHERS SYNDROME	0.00401606	0.09243026964171996
LESCH-NYHAN SYNDROME; LNS	0.00401606	0.09243026964171996
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.00401606	0.09243026964171996
LIVER FAILURE, INFANTILE, TRANSIENT	0.00401606	0.09243026964171996
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00401606	0.09243026964171996
CRYPTOSPORIDIOSIS	0.00401606	0.09243026964171996
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00387597	0.08920607566202131
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.00387597	0.08920607566202131
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00387597	0.08920607566202131
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.00387597	0.08920607566202131
INFANT BOTULISM	0.00387597	0.08920607566202131
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00387597	0.08920607566202131
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00387597	0.08920607566202131
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00387597	0.08920607566202131
CHÉDIAK-HIGASHI SYNDROME	0.00387597	0.08920607566202131
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00387597	0.08920607566202131
DEAFNESS, X-LINKED 5; DFNX5	0.00387597	0.08920607566202131
USHER SYNDROME, TYPE IE; USH1E	0.00387597	0.08920607566202131
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.00387597	0.08920607566202131
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00387597	0.08920607566202131
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00387597	0.08920607566202131
PIERSON SYNDROME	0.00387597	0.08920607566202131
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.00387597	0.08920607566202131
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00387597	0.08920607566202131
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.00387597	0.08920607566202131
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.00387597	0.08920607566202131
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00387597	0.08920607566202131
ALPERS-HUTTENLOCHER SYNDROME	0.00387597	0.08920607566202131
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.00387597	0.08920607566202131
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.00387597	0.08920607566202131
WIEACKER-WOLFF SYNDROME	0.00387597	0.08920607566202131
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00387597	0.08920607566202131
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00387597	0.08920607566202131
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00387597	0.08920607566202131
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00387597	0.08920607566202131
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.00387597	0.08920607566202131
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00387597	0.08920607566202131
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.00387597	0.08920607566202131
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00387597	0.08920607566202131
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00387597	0.08920607566202131
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00387597	0.08920607566202131
MYOPATHY, CENTRONUCLEAR, 5	0.00387597	0.08920607566202131
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00387597	0.08920607566202131
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.00387597	0.08920607566202131
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00387597	0.08920607566202131
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00387597	0.08920607566202131
SPINOCEREBELLAR ATAXIA 1	0.00387597	0.08920607566202131
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.00387597	0.08920607566202131
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00387597	0.08920607566202131
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00387597	0.08920607566202131
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00387597	0.08920607566202131
RICHARDS-RUNDLE SYNDROME; RRNS	0.00387597	0.08920607566202131
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.00387597	0.08920607566202131
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00387597	0.08920607566202131
OCULOPHARYNGODISTAL MYOPATHY	0.00387597	0.08920607566202131
GLYCOGEN STORAGE DISEASE II	0.00387597	0.08920607566202131
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00387597	0.08920607566202131
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.00387597	0.08920607566202131
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.00387597	0.08920607566202131
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.00387597	0.08920607566202131
RADICULONEUROPATHY, FATAL NEONATAL	0.00387597	0.08920607566202131
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00387597	0.08920607566202131
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00387597	0.08920607566202131
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00387597	0.08920607566202131
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00387597	0.08920607566202131
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00387597	0.08920607566202131
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00387597	0.08920607566202131
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.00387597	0.08920607566202131
ALAGILLE SYNDROME 1; ALGS1	0.00387597	0.08920607566202131
PARAPARETIC VARIANT OF GUILLAIN-BARRÉ SYNDROME	0.00387597	0.08920607566202131
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00384615	0.08851976354499216
LYMPHEDEMA, HEREDITARY, III	0.00384615	0.08851976354499216
611961 STEVENSON-CAREY SYNDROME	0.00384615	0.08851976354499216
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00384615	0.08851976354499216
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00384615	0.08851976354499216
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00384615	0.08851976354499216
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00384615	0.08851976354499216
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00384615	0.08851976354499216
MEIER-GORLIN SYNDROME 6; MGORS6	0.00384615	0.08851976354499216
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00384615	0.08851976354499216
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00384615	0.08851976354499216
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00384615	0.08851976354499216
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00384615	0.08851976354499216
POTOCKI-LUPSKI SYNDROME	0.00384615	0.08851976354499216
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00384615	0.08851976354499216
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00384615	0.08851976354499216
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00384615	0.08851976354499216
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00384615	0.08851976354499216
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00384615	0.08851976354499216
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00384615	0.08851976354499216
22Q11.2 DELETION SYNDROME	0.00384615	0.08851976354499216
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00384615	0.08851976354499216
48,XXYY SYNDROME	0.00384615	0.08851976354499216
RETT SYNDROME, CONGENITAL VARIANT	0.00384615	0.08851976354499216
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.00384615	0.08851976354499216
AICARDI SYNDROME	0.00384615	0.08851976354499216
WEBB-DATTANI SYNDROME; WEDAS	0.00384615	0.08851976354499216
SCHAAF-YANG SYNDROME; SHFYNG	0.00384615	0.08851976354499216
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00384615	0.08851976354499216
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.00384615	0.08851976354499216
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00384615	0.08851976354499216
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00384615	0.08851976354499216
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00384615	0.08851976354499216
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00384615	0.08851976354499216
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.00384615	0.08851976354499216
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00384615	0.08851976354499216
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00384615	0.08851976354499216
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.00384615	0.08851976354499216
CARCINOMA OF ESOPHAGUS	0.00384615	0.08851976354499216
3C SYNDROME	0.00384615	0.08851976354499216
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00384615	0.08851976354499216
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.00384615	0.08851976354499216
COFFIN-SIRIS SYNDROME 6; CSS6	0.00384615	0.08851976354499216
MEIER-GORLIN SYNDROME 2; MGORS2	0.00384615	0.08851976354499216
8Q24.3 MICRODELETION SYNDROME	0.00384615	0.08851976354499216
CHOPS SYNDROME; CHOPS	0.00384615	0.08851976354499216
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00384615	0.08851976354499216
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00384615	0.08851976354499216
X-LINKED EHLERS-DANLOS SYNDROME	0.00384615	0.08851976354499216
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00384615	0.08851976354499216
SWEENEY-COX SYNDROME; SWCOS	0.00384615	0.08851976354499216
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00384615	0.08851976354499216
MEIER-GORLIN SYNDROME 3; MGORS3	0.00384615	0.08851976354499216
MEIER-GORLIN SYNDROME 5; MGORS5	0.00384615	0.08851976354499216
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.00384615	0.08851976354499216
EOSINOPHILIC ESOPHAGITIS	0.00384615	0.08851976354499216
POPOV-CHANG SYNDROME; POPCHAS	0.00384615	0.08851976354499216
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00384615	0.08851976354499216
WIEDEMANN-STEINER SYNDROME	0.00384615	0.08851976354499216
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00384615	0.08851976354499216
KLEEFSTRA SYNDROME	0.00384615	0.08851976354499216
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00384615	0.08851976354499216
16P11.2P12.2 MICRODELETION SYNDROME	0.00384615	0.08851976354499216
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.00384615	0.08851976354499216
14Q12 MICRODELETION SYNDROME	0.00384615	0.08851976354499216
EMANUEL SYNDROME	0.00384615	0.08851976354499216
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00384615	0.08851976354499216
SLC35A2-CDG	0.00384615	0.08851976354499216
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00384615	0.08851976354499216
1Q21.1 MICRODUPLICATION SYNDROME	0.00384615	0.08851976354499216
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00384615	0.08851976354499216
HOLMES-GANG SYNDROME	0.00384615	0.08851976354499216
48,XXXY SYNDROME	0.00384615	0.08851976354499216
SHPRINTZEN-GOLDBERG SYNDROME	0.00384615	0.08851976354499216
FG SYNDROME TYPE 1	0.00384615	0.08851976354499216
INFANTILE DYSTONIA-PARKINSONISM	0.00384615	0.08851976354499216
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00384615	0.08851976354499216
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00384615	0.08851976354499216
FRAGILE X SYNDROME	0.00384615	0.08851976354499216
8Q12 MICRODUPLICATION SYNDROME	0.00384615	0.08851976354499216
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00384615	0.08851976354499216
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00384615	0.08851976354499216
16P13.11 MICRODELETION SYNDROME	0.00384615	0.08851976354499216
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00384615	0.08851976354499216
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00384615	0.08851976354499216
CORNELIA DE LANGE SYNDROME 1	0.00384615	0.08851976354499216
XQ28 (MECP2) DUPLICATION	0.00384615	0.08851976354499216
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00384615	0.08851976354499216
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.00384615	0.08851976354499216
TOWNES-BROCKS SYNDROME 1; TBS1	0.00384615	0.08851976354499216
GASTROESOPHAGEAL REFLUX	0.00384615	0.08851976354499216
BRANCHIOOCULOFACIAL SYNDROME	0.00384615	0.08851976354499216
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00384615	0.08851976354499216
COSTELLO SYNDROME	0.00384615	0.08851976354499216
DDOST-CDG	0.00384615	0.08851976354499216
CRI-DU-CHAT SYNDROME	0.00384615	0.08851976354499216
49,XXXXY SYNDROME	0.00384615	0.08851976354499216
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00384615	0.08851976354499216
ISOLATED POLYCYSTIC LIVER DISEASE	0.00384615	0.08851976354499216
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00384615	0.08851976354499216
PITT-HOPKINS SYNDROME	0.00384615	0.08851976354499216
PERIVENTRICULAR NODULAR HETEROTOPIA	0.00384615	0.08851976354499216
MEIER-GORLIN SYNDROME 1; MGORS1	0.00384615	0.08851976354499216
BOHRING-OPITZ SYNDROME	0.00384615	0.08851976354499216
OKAMOTO SYNDROME	0.00384615	0.08851976354499216
NK-CELL ENTEROPATHY	0.00384615	0.08851976354499216
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00384615	0.08851976354499216
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.08851976354499216
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00384615	0.08851976354499216
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00384615	0.08851976354499216
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00384615	0.08851976354499216
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00384615	0.08851976354499216
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00384615	0.08851976354499216
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00384615	0.08851976354499216
CHRISTIANSON SYNDROME	0.00384615	0.08851976354499216
MIRAGE SYNDROME; MIRAGE	0.00384615	0.08851976354499216
GENITOPATELLAR SYNDROME	0.00384615	0.08851976354499216
17P11.2 MICRODUPLICATION SYNDROME	0.00384615	0.08851976354499216
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00384615	0.08851976354499216
BOHRING-OPITZ SYNDROME	0.00384615	0.08851976354499216
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00384615	0.08851976354499216
SILVER-RUSSELL SYNDROME	0.00384615	0.08851976354499216
SMITH-LEMLI-OPITZ SYNDROME	0.00384615	0.08851976354499216
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00384615	0.08851976354499216
STICKLER SYNDROME	0.00384615	0.08851976354499216
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00384615	0.08851976354499216
CANAVAN DISEASE	0.00384615	0.08851976354499216
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.00384615	0.08851976354499216
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.08851976354499216
FRYNS SYNDROME	0.00384615	0.08851976354499216
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00384615	0.08851976354499216
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00384615	0.08851976354499216
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00384615	0.08851976354499216
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.00384615	0.08851976354499216
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00384615	0.08851976354499216
RETT SYNDROME; RTT	0.00384615	0.08851976354499216
FOCAL DERMAL HYPOPLASIA	0.00384615	0.08851976354499216
CODAS SYNDROME	0.00384615	0.08851976354499216
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00384615	0.08851976354499216
EMANUEL SYNDROME	0.00384615	0.08851976354499216
FOLLICULAR LYMPHOMA	0.0035461	0.08161406432585747
PRIMARY MYELOFIBROSIS	0.0035461	0.08161406432585747
LYMPHANGIOLEIOMYOMATOSIS	0.0035461	0.08161406432585747
HERMANSKY-PUDLAK SYNDROME	0.0035461	0.08161406432585747
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0035461	0.08161406432585747
ADIPOSIS DOLOROSA	0.0035461	0.08161406432585747
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0035461	0.08161406432585747
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0035461	0.08161406432585747
ANISOCORIA	0.0035461	0.08161406432585747
THYMOMA	0.0035461	0.08161406432585747
THYMIC CARCINOMA	0.0035461	0.08161406432585747
REFRACTORY ANEMIA	0.0035461	0.08161406432585747
PERIPARTUM CARDIOMYOPATHY	0.0035461	0.08161406432585747
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.08161406432585747
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0035461	0.08161406432585747
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0035461	0.08161406432585747
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0035461	0.08161406432585747
CHOLANGIOCARCINOMA	0.0035461	0.08161406432585747
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0035461	0.08161406432585747
PANHYPOPITUITARISM	0.0035461	0.08161406432585747
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.08161406432585747
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0035461	0.08161406432585747
MAST CELL SARCOMA	0.0035461	0.08161406432585747
SATOYOSHI SYNDROME	0.0035461	0.08161406432585747
NON-FUNCTIONING PARAGANGLIOMA	0.0035461	0.08161406432585747
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0035461	0.08161406432585747
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.08161406432585747
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.0035461	0.08161406432585747
CONGENITAL ANALBUMINEMIA	0.0035461	0.08161406432585747
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0035461	0.08161406432585747
POST-TRAUMATIC PITUITARY DEFICIENCY	0.0035461	0.08161406432585747
FAMILIAL THYROID DYSHORMONOGENESIS	0.0035461	0.08161406432585747
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0035461	0.08161406432585747
THYROID HEMIAGENESIS	0.0035461	0.08161406432585747
THYROID HYPOPLASIA	0.0035461	0.08161406432585747
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.08161406432585747
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0035461	0.08161406432585747
ACROMEGALY	0.0035461	0.08161406432585747
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0035461	0.08161406432585747
HEMOCHROMATOSIS, TYPE 4; HFE4	0.0035461	0.08161406432585747
ADULT-ONSET STILL DISEASE	0.0035461	0.08161406432585747
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.08161406432585747
KLATSKIN TUMOR	0.0035461	0.08161406432585747
KUFOR-RAKEB SYNDROME	0.0035461	0.08161406432585747
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0035461	0.08161406432585747
KIKUCHI-FUJIMOTO DISEASE	0.0035461	0.08161406432585747
X-LINKED AGAMMAGLOBULINEMIA	0.0035461	0.08161406432585747
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.0035461	0.08161406432585747
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.08161406432585747
INSULIN-RESISTANCE SYNDROME TYPE B	0.0035461	0.08161406432585747
ISOLATED AGAMMAGLOBULINEMIA	0.0035461	0.08161406432585747
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0035461	0.08161406432585747
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.0035461	0.08161406432585747
HEMORRHAGIC FEVER-RENAL SYNDROME	0.0035461	0.08161406432585747
PERIPHERAL HYPOTHYROIDISM	0.0035461	0.08161406432585747
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.0035461	0.08161406432585747
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0035461	0.08161406432585747
BLACKFAN-DIAMOND ANEMIA	0.0035461	0.08161406432585747
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.0035461	0.08161406432585747
PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.08161406432585747
AREGENERATIVE ANEMIA	0.0035461	0.08161406432585747
THYMIC EPITHELIAL NEOPLASM	0.0035461	0.08161406432585747
TUBERCULOSIS	0.0035461	0.08161406432585747
CRONKHITE-CANADA SYNDROME	0.0035461	0.08161406432585747
MULTIPLE MYELOMA	0.0035461	0.08161406432585747
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0035461	0.08161406432585747
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.0035461	0.08161406432585747
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.0035461	0.08161406432585747
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0035461	0.08161406432585747
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.08161406432585747
GAUCHER DISEASE	0.0035461	0.08161406432585747
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.08161406432585747
MANTLE CELL LYMPHOMA	0.0035461	0.08161406432585747
EBSTEIN MALFORMATION	0.0035461	0.08161406432585747
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0035461	0.08161406432585747
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.08161406432585747
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.08161406432585747
EOSINOPHILIC FASCIITIS	0.0035461	0.08161406432585747
DUBIN-JOHNSON SYNDROME	0.0035461	0.08161406432585747
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0035461	0.08161406432585747
SOMATOMAMMOTROPINOMA	0.0035461	0.08161406432585747
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0035461	0.08161406432585747
CYCLIC NEUTROPENIA	0.0035461	0.08161406432585747
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0035461	0.08161406432585747
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0035461	0.08161406432585747
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0035461	0.08161406432585747
CHRONIC MYELOID LEUKEMIA	0.0035461	0.08161406432585747
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.08161406432585747
TETRASOMY 9P	0.0035461	0.08161406432585747
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.07936272122432188
TRISOMY XQ28	0.00344828	0.07936272122432188
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00344828	0.07936272122432188
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.07936272122432188
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.07936272122432188
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.07936272122432188
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00344828	0.07936272122432188
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.00344828	0.07936272122432188
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00344828	0.07936272122432188
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.07936272122432188
ALZHEIMER DISEASE 3; AD	0.00344828	0.07936272122432188
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.07936272122432188
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.07936272122432188
ATAXIA-TELANGIECTASIA	0.00344828	0.07936272122432188
THORACOMELIC DYSPLASIA	0.00344828	0.07936272122432188
FRIED SYNDROME	0.00344828	0.07936272122432188
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00344828	0.07936272122432188
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.07936272122432188
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.07936272122432188
PSEUDOACHONDROPLASIA	0.00344828	0.07936272122432188
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.00344828	0.07936272122432188
JOUBERT SYNDROME	0.00344828	0.07936272122432188
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.07936272122432188
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.07936272122432188
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.07936272122432188
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00344828	0.07936272122432188
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.07936272122432188
OROFACIODIGITAL SYNDROME TYPE 6	0.00344828	0.07936272122432188
HYDROCEPHALUS, NORMAL-PRESSURE	0.00344828	0.07936272122432188
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00344828	0.07936272122432188
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.07936272122432188
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00344828	0.07936272122432188
FREE SIALIC ACID STORAGE DISEASE	0.00344828	0.07936272122432188
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.00344828	0.07936272122432188
NON-DISTAL MONOSOMY 10Q	0.00344828	0.07936272122432188
NEUROFERRITINOPATHY	0.00344828	0.07936272122432188
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00344828	0.07936272122432188
KUFOR-RAKEB SYNDROME	0.00344828	0.07936272122432188
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.07936272122432188
SHWACHMAN-DIAMOND SYNDROME	0.00344828	0.07936272122432188
RICHARDS-RUNDLE SYNDROME	0.00344828	0.07936272122432188
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00344828	0.07936272122432188
BENIGN HEREDITARY CHOREA	0.00344828	0.07936272122432188
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.07936272122432188
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.07936272122432188
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.07936272122432188
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.07936272122432188
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00344828	0.07936272122432188
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.00344828	0.07936272122432188
OSTEOCHONDRITIS DISSECANS	0.00344828	0.07936272122432188
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00344828	0.07936272122432188
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.07936272122432188
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00344828	0.07936272122432188
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00344828	0.07936272122432188
CORTICOBASAL SYNDROME	0.00344828	0.07936272122432188
DOWN SYNDROME	0.00344828	0.07936272122432188
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.07936272122432188
DYSTONIA 16; DYT16	0.00344828	0.07936272122432188
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.07936272122432188
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.07936272122432188
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00344828	0.07936272122432188
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00344828	0.07936272122432188
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.07936272122432188
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.07936272122432188
DYSTONIA 23; DYT23	0.00344828	0.07936272122432188
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00344828	0.07936272122432188
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.07936272122432188
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.07936272122432188
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.07936272122432188
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00344828	0.07936272122432188
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.07936272122432188
PARTINGTON SYNDROME	0.00344828	0.07936272122432188
MELNICK-NEEDLES SYNDROME	0.00344828	0.07936272122432188
COHEN-GIBSON SYNDROME; COGIS	0.00344828	0.07936272122432188
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00344828	0.07936272122432188
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.07936272122432188
MASA SYNDROME	0.00344828	0.07936272122432188
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00344828	0.07936272122432188
MUCOLIPIDOSIS TYPE IV	0.00344828	0.07936272122432188
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.07936272122432188
LERI PLEONOSTEOSIS	0.00344828	0.07936272122432188
JOUBERT SYNDROME 24	0.00344828	0.07936272122432188
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.07936272122432188
NIEMANN-PICK DISEASE TYPE C	0.00344828	0.07936272122432188
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.07936272122432188
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.07936272122432188
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00344828	0.07936272122432188
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.07936272122432188
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00344828	0.07936272122432188
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00344828	0.07936272122432188
JOUBERT SYNDROME WITH RENAL DEFECT	0.00344828	0.07936272122432188
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.07936272122432188
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.00344828	0.07936272122432188
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.07936272122432188
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.07936272122432188
ABETA AMYLOIDOSIS, IOWA TYPE	0.00344828	0.07936272122432188
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.07936272122432188
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.07936272122432188
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00344828	0.07936272122432188
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.07936272122432188
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00344828	0.07936272122432188
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.07936272122432188
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00344828	0.07936272122432188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.00344828	0.07936272122432188
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.07936272122432188
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.07936272122432188
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.07936272122432188
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.07936272122432188
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.07936272122432188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.00344828	0.07936272122432188
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00344828	0.07936272122432188
FOIX-CHAVANY-MARIE SYNDROME	0.00344828	0.07936272122432188
TETRASOMY 18P	0.00344828	0.07936272122432188
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00344828	0.07936272122432188
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.07936272122432188
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.07936272122432188
FILIPPI SYNDROME; FLPIS	0.00316456	0.0728328595930841
SCHINZEL-GIEDION SYNDROME	0.00316456	0.0728328595930841
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.0728328595930841
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.0728328595930841
SPASTIC PARAPLEGIA 16, X-LINKED	0.00316456	0.0728328595930841
ALBINISM, OCULAR, TYPE I	0.00316456	0.0728328595930841
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.0728328595930841
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.0728328595930841
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00316456	0.0728328595930841
16Q24.3 MICRODELETION SYNDROME	0.00316456	0.0728328595930841
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00316456	0.0728328595930841
CRANIOTELENCEPHALIC DYSPLASIA	0.00316456	0.0728328595930841
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00316456	0.0728328595930841
FUMARASE DEFICIENCY; FMRD	0.00316456	0.0728328595930841
INFANTILE NEUROAXONAL DYSTROPHY	0.00316456	0.0728328595930841
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.0728328595930841
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00316456	0.0728328595930841
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.0728328595930841
BLUE CONE MONOCHROMATISM	0.00316456	0.0728328595930841
N SYNDROME	0.00316456	0.0728328595930841
ACRODERMATITIS ENTEROPATHICA	0.00316456	0.0728328595930841
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.0728328595930841
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.00316456	0.0728328595930841
CHROMOSOME XP11.3 DELETION SYNDROME	0.00316456	0.0728328595930841
GAPO SYNDROME	0.00316456	0.0728328595930841
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00316456	0.0728328595930841
MUCOLIPIDOSIS IV; ML4	0.00316456	0.0728328595930841
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.0728328595930841
WAGR SYNDROME	0.00316456	0.0728328595930841
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.0728328595930841
INTESTINAL LYMPHANGIECTASIA	0.00316456	0.0728328595930841
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00316456	0.0728328595930841
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00316456	0.0728328595930841
PRADER-WILLI-LIKE SYNDROME	0.00316456	0.0728328595930841
CONGENITAL TOXOPLASMOSIS	0.00316456	0.0728328595930841
TREACHER-COLLINS SYNDROME	0.00316456	0.0728328595930841
CONE ROD DYSTROPHY	0.00316456	0.0728328595930841
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.0728328595930841
JALILI SYNDROME	0.00316456	0.0728328595930841
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.0728328595930841
HYPERTRYPTOPHANEMIA; HYPTRP	0.00316456	0.0728328595930841
TRIPLE A SYNDROME	0.00316456	0.0728328595930841
FETAL METHYLMERCURY SYNDROME	0.00316456	0.0728328595930841
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00316456	0.0728328595930841
X-LINKED RETINAL DYSPLASIA	0.00316456	0.0728328595930841
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00316456	0.0728328595930841
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00316456	0.0728328595930841
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.0728328595930841
GOLDENHAR SYNDROME	0.00316456	0.0728328595930841
FANCONI ANEMIA	0.00316456	0.0728328595930841
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.0728328595930841
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.0728328595930841
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.0728328595930841
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00316456	0.0728328595930841
APERT SYNDROME	0.00316456	0.0728328595930841
RFT1-CDG	0.00316456	0.0728328595930841
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00316456	0.0728328595930841
HALLERMANN-STREIFF SYNDROME	0.00316456	0.0728328595930841
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.0728328595930841
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.0728328595930841
BLUE CONE MONOCHROMACY; BCM	0.00316456	0.0728328595930841
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00316456	0.0728328595930841
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00316456	0.0728328595930841
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00316456	0.0728328595930841
LOWRY-WOOD SYNDROME	0.00316456	0.0728328595930841
N SYNDROME	0.00316456	0.0728328595930841
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00316456	0.0728328595930841
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.0728328595930841
ABLEPHARON MACROSTOMIA SYNDROME	0.00316456	0.0728328595930841
BROOKE-SPIEGLER SYNDROME	0.00316456	0.0728328595930841
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00316456	0.0728328595930841
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00316456	0.0728328595930841
MOEBIUS SYNDROME	0.00316456	0.0728328595930841
MICROPHTHALMIA, LENZ TYPE	0.00316456	0.0728328595930841
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00316456	0.0728328595930841
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.0728328595930841
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00316456	0.0728328595930841
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00316456	0.0728328595930841
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00316456	0.0728328595930841
CONE-ROD DYSTROPHY 17; CORD17	0.00316456	0.0728328595930841
GILLESPIE SYNDROME; GLSP	0.00316456	0.0728328595930841
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00316456	0.0728328595930841
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.0728328595930841
OCULAR ALBINISM	0.00316456	0.0728328595930841
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00316456	0.0728328595930841
RENAL COLOBOMA SYNDROME	0.00316456	0.0728328595930841
FOUNTAIN SYNDROME	0.00316456	0.0728328595930841
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00316456	0.0728328595930841
PETERS PLUS SYNDROME	0.00316456	0.0728328595930841
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00316456	0.0728328595930841
OCULOCUTANEOUS ALBINISM	0.00316456	0.0728328595930841
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00316456	0.0728328595930841
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00316456	0.0728328595930841
COFFIN-SIRIS SYNDROME 4; CSS4	0.00316456	0.0728328595930841
COFFIN-SIRIS SYNDROME 3; CSS3	0.00316456	0.0728328595930841
COFFIN-SIRIS SYNDROME 2; CSS2	0.00316456	0.0728328595930841
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00316456	0.0728328595930841
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00316456	0.0728328595930841
JABERI-ELAHI SYNDROME; JABELS	0.00316456	0.0728328595930841
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.0728328595930841
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.0728328595930841
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.0728328595930841
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.0728328595930841
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00316456	0.0728328595930841
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.0728328595930841
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.0728328595930841
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00316456	0.0728328595930841
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00316456	0.0728328595930841
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.00316456	0.0728328595930841
COFFIN-SIRIS SYNDROME 1; CSS1	0.00316456	0.0728328595930841
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.0728328595930841
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00316456	0.0728328595930841
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00316456	0.0728328595930841
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00316456	0.0728328595930841
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00316456	0.0728328595930841
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00316456	0.0728328595930841
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00316456	0.0728328595930841
HELSMOORTEL-VAN DER AA SYNDROME	0.00316456	0.0728328595930841
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.0728328595930841
CONGENITAL RUBELLA SYNDROME	0.00316456	0.0728328595930841
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.0728328595930841
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00316456	0.0728328595930841
MULTIPLE SULFATASE DEFICIENCY	0.00316456	0.0728328595930841
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.0728328595930841
CROUZON SYNDROME	0.00316456	0.0728328595930841
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00316456	0.0728328595930841
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00316456	0.0728328595930841
BUSCHKE-OLLENDORFF SYNDROME	0.00316456	0.0728328595930841
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00316456	0.0728328595930841
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.0728328595930841
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.0728328595930841
MMEP SYNDROME	0.00316456	0.0728328595930841
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00316456	0.0728328595930841
FISH-EYE DISEASE	0.00316456	0.0728328595930841
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00316456	0.0728328595930841
ASCHER SYNDROME	0.00316456	0.0728328595930841
BONNEMANN-MEINECKE-REICH SYNDROME	0.00316456	0.0728328595930841
AYMÉ-GRIPP SYNDROME	0.00316456	0.0728328595930841
VOGT-KOYANAGI-HARADA DISEASE	0.00316456	0.0728328595930841
UNILATERAL POLYMICROGYRIA	0.00316456	0.0728328595930841
NEONATAL ADRENOLEUKODYSTROPHY	0.00316456	0.0728328595930841
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00316456	0.0728328595930841
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00316456	0.0728328595930841
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.0728328595930841
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.0728328595930841
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.0728328595930841
OCULOCUTANEOUS ALBINISM TYPE 2	0.00316456	0.0728328595930841
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00316456	0.0728328595930841
OCULOCUTANEOUS ALBINISM TYPE 4	0.00316456	0.0728328595930841
JOUBERT SYNDROME 3; JBTS3	0.00316456	0.0728328595930841
JOUBERT SYNDROME 2	0.00316456	0.0728328595930841
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.0728328595930841
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.00316456	0.0728328595930841
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00316456	0.0728328595930841
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.0728328595930841
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00316456	0.0728328595930841
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00316456	0.0728328595930841
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.0728328595930841
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00316456	0.0728328595930841
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00316456	0.0728328595930841
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00316456	0.0728328595930841
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00316456	0.0728328595930841
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00316456	0.0728328595930841
RETINITIS PIGMENTOSA 20	0.00316456	0.0728328595930841
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.0728328595930841
BRADYOPSIA	0.00316456	0.0728328595930841
RETINITIS PIGMENTOSA 27; RP27	0.00316456	0.0728328595930841
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00316456	0.0728328595930841
COHEN SYNDROME	0.00316456	0.0728328595930841
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.0728328595930841
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.0728328595930841
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.0728328595930841
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.0728328595930841
PAPILLOMA OF CHOROID PLEXUS	0.00316456	0.0728328595930841
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00316456	0.0728328595930841
CONE DYSTROPHY 4	0.00316456	0.0728328595930841
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00316456	0.0728328595930841
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.0728328595930841
X-LINKED RECESSIVE OCULAR ALBINISM	0.00316456	0.0728328595930841
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.0728328595930841
PROLIDASE DEFICIENCY	0.00316456	0.0728328595930841
ADIE PUPIL	0.00308642	0.07103445487059389
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00308642	0.07103445487059389
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00308642	0.07103445487059389
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00308642	0.07103445487059389
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00308642	0.07103445487059389
NON-DISTAL MONOSOMY 20Q	0.00308642	0.07103445487059389
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00308642	0.07103445487059389
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA TYPE 1	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA TYPE 2	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA TYPE 10	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00308642	0.07103445487059389
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00308642	0.07103445487059389
HOYERAAL-HREIDARSSON SYNDROME	0.00308642	0.07103445487059389
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00308642	0.07103445487059389
NEONATAL MARFAN SYNDROME	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00308642	0.07103445487059389
SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	0.00308642	0.07103445487059389
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00308642	0.07103445487059389
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00308642	0.07103445487059389
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.00308642	0.07103445487059389
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00308642	0.07103445487059389
REFSUM DISEASE	0.00308642	0.07103445487059389
FACIAL SPASM	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00308642	0.07103445487059389
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00308642	0.07103445487059389
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00308642	0.07103445487059389
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.00308642	0.07103445487059389
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00308642	0.07103445487059389
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00308642	0.07103445487059389
PERRAULT SYNDROME 5; PRLTS5	0.00308642	0.07103445487059389
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.00308642	0.07103445487059389
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00308642	0.07103445487059389
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00308642	0.07103445487059389
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00308642	0.07103445487059389
GLYCINE ENCEPHALOPATHY; GCE	0.00308642	0.07103445487059389
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00308642	0.07103445487059389
LOEYS-DIETZ SYNDROME 5	0.00308642	0.07103445487059389
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00308642	0.07103445487059389
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00308642	0.07103445487059389
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00308642	0.07103445487059389
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00308642	0.07103445487059389
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.00308642	0.07103445487059389
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00308642	0.07103445487059389
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00308642	0.07103445487059389
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00308642	0.07103445487059389
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.00308642	0.07103445487059389
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.00308642	0.07103445487059389
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00308642	0.07103445487059389
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00308642	0.07103445487059389
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00308642	0.07103445487059389
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.00308642	0.07103445487059389
IMMUNODEFICIENCY 23; IMD23	0.00308642	0.07103445487059389
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00308642	0.07103445487059389
VERVERI-BRADY SYNDROME; VERBRAS	0.00308642	0.07103445487059389
NEMALINE MYOPATHY 4	0.00308642	0.07103445487059389
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00308642	0.07103445487059389
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00308642	0.07103445487059389
HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	0.00308642	0.07103445487059389
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00308642	0.07103445487059389
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.00308642	0.07103445487059389
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00308642	0.07103445487059389
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00308642	0.07103445487059389
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00308642	0.07103445487059389
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00308642	0.07103445487059389
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00308642	0.07103445487059389
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00308642	0.07103445487059389
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00308642	0.07103445487059389
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00308642	0.07103445487059389
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.00308642	0.07103445487059389
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA TYPE 31	0.00308642	0.07103445487059389
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00308642	0.07103445487059389
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00308642	0.07103445487059389
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00308642	0.07103445487059389
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00308642	0.07103445487059389
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00308642	0.07103445487059389
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00308642	0.07103445487059389
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00308642	0.07103445487059389
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00308642	0.07103445487059389
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00308642	0.07103445487059389
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00308642	0.07103445487059389
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.00308642	0.07103445487059389
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00308642	0.07103445487059389
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00308642	0.07103445487059389
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.00308642	0.07103445487059389
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00308642	0.07103445487059389
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.00308642	0.07103445487059389
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	0.00308642	0.07103445487059389
CHROMOSOME 2Q37 DELETION SYNDROME	0.00308642	0.07103445487059389
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00308642	0.07103445487059389
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V	0.00308642	0.07103445487059389
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00308642	0.07103445487059389
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00308642	0.07103445487059389
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00308642	0.07103445487059389
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00308642	0.07103445487059389
PELIZAEUS-MERZBACHER DISEASE	0.00308642	0.07103445487059389
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.00308642	0.07103445487059389
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00294985	0.067891274259505
FOCAL MYOSITIS	0.00294985	0.067891274259505
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00294985	0.067891274259505
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.00294985	0.067891274259505
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00294985	0.067891274259505
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00294985	0.067891274259505
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00294985	0.067891274259505
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00294985	0.067891274259505
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00294985	0.067891274259505
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00294985	0.067891274259505
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00294985	0.067891274259505
AMYOTROPHIC LATERAL SCLEROSIS 1	0.00294985	0.067891274259505
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.00294985	0.067891274259505
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00294985	0.067891274259505
MULTIPLE OSTEOCHONDROMAS	0.00294985	0.067891274259505
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00294985	0.067891274259505
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00294985	0.067891274259505
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00294985	0.067891274259505
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00294985	0.067891274259505
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00294985	0.067891274259505
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.00294985	0.067891274259505
159100 MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE	0.00294985	0.067891274259505
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00294985	0.067891274259505
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00294985	0.067891274259505
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00294985	0.067891274259505
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00294985	0.067891274259505
EPISODIC ATAXIA, TYPE 8	0.00294985	0.067891274259505
SPASTIC PARAPLEGIA TYPE 2	0.00294985	0.067891274259505
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00294985	0.067891274259505
NIJMEGEN BREAKAGE SYNDROME	0.00294985	0.067891274259505
NOONAN SYNDROME	0.00294985	0.067891274259505
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES	0.00294985	0.067891274259505
SUPRABULBAR PARESIS, CONGENITAL	0.00294985	0.067891274259505
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00294985	0.067891274259505
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00294985	0.067891274259505
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00294985	0.067891274259505
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00294985	0.067891274259505
ISAAC SYNDROME	0.00294985	0.067891274259505
BETA-THALASSEMIA	0.00294985	0.067891274259505
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00294985	0.067891274259505
THYROID ECTOPIA	0.00294985	0.067891274259505
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00294985	0.067891274259505
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00294985	0.067891274259505
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00294985	0.067891274259505
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00294985	0.067891274259505
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.00294985	0.067891274259505
MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION	0.00294985	0.067891274259505
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.00294985	0.067891274259505
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00294985	0.067891274259505
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00294985	0.067891274259505
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00294985	0.067891274259505
KEARNS-SAYRE SYNDROME; KSS	0.00294985	0.067891274259505
COWCHOCK SYNDROME; COWCK	0.00294985	0.067891274259505
JUVENILE PRIMARY LATERAL SCLEROSIS	0.00294985	0.067891274259505
GLYCOGEN STORAGE DISEASE IXB	0.00294985	0.067891274259505
CUTIS LAXA	0.00294985	0.067891274259505
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00294985	0.067891274259505
EPISODIC ATAXIA TYPE 7	0.00294985	0.067891274259505
PYLE DISEASE; PYL	0.00294985	0.067891274259505
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00294985	0.067891274259505
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00294985	0.067891274259505
MUSCLE GLYCOGENOSIS, X-LINKED	0.00294985	0.067891274259505
%300211 EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX	0.00294985	0.067891274259505
CRYOGLOBULINEMIC VASCULITIS	0.00294985	0.067891274259505
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00294985	0.067891274259505
SPONDYLOOCULAR SYNDROME; SOS	0.00294985	0.067891274259505
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00294985	0.067891274259505
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00294985	0.067891274259505
GLYCOGEN STORAGE DISEASE V; GSD5	0.00294985	0.067891274259505
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00294985	0.067891274259505
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00294985	0.067891274259505
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00294985	0.067891274259505
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00294985	0.067891274259505
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00294985	0.067891274259505
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00294985	0.067891274259505
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00294985	0.067891274259505
STIFF SKIN SYNDROME	0.00294985	0.067891274259505
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00294985	0.067891274259505
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00294985	0.067891274259505
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00294985	0.067891274259505
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00294985	0.067891274259505
RETT SYNDROME	0.00294985	0.067891274259505
GLYCOGEN STORAGE DISEASE VII	0.00294985	0.067891274259505
HEREDITARY SPHEROCYTOSIS	0.00294985	0.067891274259505
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.00294985	0.067891274259505
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.00294985	0.067891274259505
EPISODIC ATAXIA, TYPE 7; EA7	0.00294985	0.067891274259505
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00294985	0.067891274259505
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00294985	0.067891274259505
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00294985	0.067891274259505
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00294985	0.067891274259505
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00294985	0.067891274259505
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.00294985	0.067891274259505
NAKAJO-NISHIMURA SYNDROME	0.00294985	0.067891274259505
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00294985	0.067891274259505
ADRENOCORTICAL CARCINOMA	0.00294985	0.067891274259505
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00294985	0.067891274259505
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00294985	0.067891274259505
